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Summary
External Beam Radiotherapy is a method tha t is widely used in treating tumours in 
cancer patients. Image acquisition methods such as 4 - dimensional computed tomogra­
phy (4DCT) and cone-beam computed tomography(CBCT) are used frequently when 
planning and delivering treatm ent strategies. However, patients involuntary movements 
such as respiratory motion cause ambiguities (blurriness, etc ) when locating tumours 
in these scanned images. These aforementioned ambiguities in tum our location could 
lead to higher dosed treatm ent plans. This could be highly undesirable for the patients, 
as it will easily damage healthy tissues around the tum our as well. However, two main 
problems occur in external beam radiotherapy and need to be taken into account when 
estimating the motion of a tumour. First, the tum our movement as the patient breathes 
and second, the delay in the time needed for the treatm ent delivery system (usually a 
linear accelerator) to move and produce a beam profile tha t conforms to the treatm ent 
plan at a particular angle. This means tha t ideally the patients internal organ configu­
ration should be dynamically predicted in order to  minimize treating normal tissue at 
the tum our margin.
We propose tha t a dynamic CT volume (one breathing cycle) be used, to  determine 
a patient specific motion model by using iterative registration methods to determine 
the transformation parameters to locate the tumour and its movements. A correlation 
model was built to determine the motion between the lung tum our and the internal 
surrogate organ. Therefore, when the treatm ent beams impinge on the patient during 
radiotherapy the tum our position can then be determined and targeted within ±3m m  
from the CTV-PTV margin in any direction which accounts for geometric errors in 
treatm ent planning. As a consequence, reduces the overall PTV margin of error in 
tumour motion considering imperceptible penetration, which leads to reduced patient 
dose in the treatm ent plan.
K ey  w ords: Radiotherapy, Respiratory-induced Motion, Image Registration, Lung 
tumour margins. Modeling, Planning Target Volume (PTV) margin.
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Chapter 1
Introduction
External beam radiotherapy (EBRT) is a vastly popular method in treating cancer 
patients. However, when treating cancer patients with radiotherapy, it is to be noted 
tha t the involuntary movements in a patient, could cause undesirable effects th a t would 
later determine the dosimetry. Such involuntary movements include respiratory mo­
tion, digestion, blood flow, e tc ... are to name a few. In this research however, focus is 
mainly on the affects on radiotherapy procedures due to respiratory-induced motion. 
Respiratory-induced motion causes ambiguities tha t can distort the shape of an organ 
or tum our itself, tha t could lead to undesirable dose delivery in the treatm ent stages 
in radiotherapy procedures for patients tha t have developed tumours in thoracic and 
abdominal regions, mainly lung cancer patients. This respiratory-induced motion if 
not properly treated, could lead to higher dose delivery which could cause to lower the 
levels of healthy tissue sparing or lower dose delivery which could expedite the growth 
of the tumour. It is therefore im portant to find a feasible motion model th a t could 
account for respiratory motion during radiotherapy treatm ent which would ultimately 
lead to the reduction of the planning target volume (PTV) margin th a t would benefit 
the patient’s treatm ent plan. Therefore, first and foremost, a brief overview of the cur­
rent radiotherapy procedures, different tum our volumes, the current state of scientific 
understanding, technical methodology in imaging and finally, treatm ent planning and 
treatm ent delivery is discussed.
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1.1 Thoracic and Abdominal Cancer
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Figure 1.1: Cancer statistics for the year 2010 as issued by the cancer research UK 
[122]
Lung cancer is one of the most prevalent causes of death in the world currently. Ac­
cording to the statistics shown in Figure 1.1 as of 2010 in UK [122], for both men and 
women the most common cause of cancer death is lung cancer. It estimates a stag­
gering 19,410 deaths for men and 15,449 deaths for women in the year of 2010 in UK 
with an extremely poor survival rate of 5-10% for five years of survival. Moreover, for 
patients in the age range of 15-39 have the highest average of survival rate for lung 
cancer with only 26% [122]. Smoking tobacco is the single greatest risk factor for lung 
cancer related deaths, which accounts for 88% male and 84% female deaths in UK. 
Other known risk factors that cause lung cancer include passive smoke and occupa­
tional and environmental exposures to a carcinogen (such as asbestos, heavy metals, 
radon gas, talc dust, etc..) [122]. The most common cancer in the abdomen is bowel 
cancer with an average of 8600 for men and 7308 for women [122]. Although, the main
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reason for abdominal cancer is unknown and is still at large, it is assumed th a t it is 
mainly hereditary and a person’s diet may also lead to the development of abdominal 
cancer. The available treatm ent options for various stages of these cancers can be di­
vided into 3 main categories, namely, surgery, radiotherapy and/or chemotherapy. For 
the purposes of this research however, the focus will only be on radiotherapy treatm ent 
administered externally to the patients during the treatm ent stages^ and in specific for 
tumours in the thoracic and abdominal cavities.
1.2 Diagnostic Imaging
W ith the rapid development and proliferation of medical imaging technologies, scien­
tists and physicians are able to glean potentially life threatening information by peering 
non-invasively into the human body. Beyond the simple visualization and inspection 
of the anatomical structures, medical imaging has become a tool for surgical planning, 
simulation, intra-operative navigation, radiotherapy treatm ent planning and tracking 
the progress of disease [7]. These technologies include X-ray, computed tomography 
(CT), magnetic resonance imaging (MRI) and nuclear medicine imaging^ technologies. 
These can be divided into 2 main categories, namely, modalities th a t use ionising ra­
diation and modalities tha t use non-ionising radiation. When radiation is ionised, it 
releases an electron from an atom or a molecule due to its particles’ immense kinetic 
energy. Although, CT scans generate fast, detailed 3D volumetric image datasets, the 
main disadvantage is that these powerful rays tha t are emitted during a CT scan, are 
capable of directly or indirectly damaging the DNA. Modalities such as CT and PET 
use ionisation radiation when imaging. A typical CT scanner uses an X-ray source as 
an emitter and a detector on opposing sides as shown in Figure 1.2.
A typical CT scan generates a 3-dimensional (3D) volume of data obtained by imaging 
a large number of 2-dimensional (2D) slices around a single axis of rotation.
 ^which includes treatment planning and delivery stages which will be discussed in detail later in the 
chapter
^which generally includes single-photon emission computed tomography (SPECT) and positron 
emission tomography(PET) imaging technologies.
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Figure 1.2; Illustration of the operation of a CT scanner
1.3 Radiotherapy
Radiotherapy, also known as radiation therapy or radiation oncology, is a widely used 
localised non-invasive treatm ent method [20] for cancer patients, among other invasive 
treatm ent methods such as, chemotherapy and surgery. The mechanism of the radio­
therapy procedure is simply to cause irreparable damage to the DNA of the cancerous 
cells by exposing the tumour cells to ionizing radiation. Radiotherapy can be broadly 
sub-categorized to three distinct radiotherapy delivery approaches, namely internal 
(brachytherapy), external beam radiotherapy (EBRT/XRT) and systematic radioiso­
tope therapy (unsealed source radiotherapy).
1 .3 .1  In tern a l R a d io th era p y
Internal radiotherapy also known as sealed source therapy, implant therapy, intersti­
tial radiation or intra-cavity radiation, is a minimally invasive procedure that uses 
radioactive sources such as radioactive iodine (I^^^), cesium (Cs^^^), iridium (Ir^® )^, 
phosphorus (P^^), cobalt (Co^®) in implants or seeds, placed directly into or near the 
tum our 1.3 [83].
Brachytherapy is performed in three straight forward steps:
Treatment Planning:
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F ig u re  1.3: Interstitial Brachytherapy procedure performing the seed implantation on 
a prostate cancer patient, using a needle [83].
clinical examination is performed to obtain a C T  or M R I image scan o f the tum our  
and to plan the optimal distribution o f treatment. A t this stage, the applicators 
or source carriers that deliver the radiation, typically, non radioactive needles or 
plastic catheters, will also be discussed.
Insertion  of applicators:
In  order to ensure the applicators are correctly positioned aligning with the tu­
mour, by using imaging technologies such as X-ray, fluoroscopy, or C T  to guide 
placing the radioactive sources.
3D Virtual P a tien t Creation and Optim izing the Irradiation Plan:
With the C T  image scans obtained, a 3-dimensional (3D) rendering o f the appli­
cators, the treatment volume and the surrounding healthy tissues bear a spatial re­
lationship that would help optimize the irradiation plan in the spatial and temporal 
domains fo r  the tumour. The graphical representation will guide the oncologists 
to deliver a patient specific dose also sometim es referred to as dose-painting.
The main advantage in using internal radiotherapy is tha t it increases the chance of 
healthy tissue sparing as the radiation delivered is concentrated on or near the tumour. 
One of the main disadvantages of brachytherapy however is that, it is unsuitable for 
aggressive tumours as the radiation strength is insufficient for treatm ent of tumours
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of such magnitude. Another disadvantage is the patient will remain radioactive for 
several days after the treatment session. Internal radiotherapy is generally used in 
treating tumours of the head, neck, thyroid, female reproductive system, prostate or 
breast.
1 .3 .2  S y s te m a tic  R a d io iso to p e  T h era p y
Unsealed source radiotherapy also known as systematic radioisotope therapy or source 
radioisotope therapy, uses soluble radioactive substances, such as radioactive iodine 
tha t are administered to the body by means of infusion or oral ingestion [122]. 
However, one obvious disadvantage is tha t patients who received treatment are consid­
ered to be radioactive throughout the duration of the procedure and will remain so for 
several weeks as well much like in brachytherapy [122]. Unsealed source radiotherapy 
is generally used to treat patients with thyroid cancers.
1 .3 .3  E x tern a l B ea m  R a d io th era p y
External beam radiotherapy conventionally uses photon^ beams such as, high energy 
X-rays, gamma rays or charged particles to treat cancer patients. Photons allow in­
teractions at longer distances, therefore, they can even penetrate to treat deep seated 
tumours. External beam radiotherapy procedures are carried out with the aid of linear 
accelerators also known as LIN AC machines [89, 120] [Appendix A describes the full 
functionality of a Linac machine]. Figure 1.4 illustrates external thoracic radiation 
therapy given to a patient suffering from pleural mesothelioma cancer.
There are numerous advantages of using EBRT as opposed to the other types of radio­
therapy treatm ent procedures. These mainly depend on a patient’s age, health and the 
stage of the cancer. Since, EBRT is a non-invasive procedure patients are less prone 
to  having any of the risks of surgery. EBRT is painless and does not have the residual 
contamination issues with radioactivity at the end of the session tha t is associated with
^Photons are quantum energy packets that carry no electrical charge or rest mass, but can have 
varying energy levels in the electromagnetic spectrum that, can ultimately emit energy rays such as, 
high energy X-rays, gamma rays, etc . . .
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Figure 1.4; Illustration of the external beam radiation therapy performed on a patient 
with pleural mesothelioma cancer (cancer attacking the membranes of the heart, lungs 
and the abdominal cavity) [129].
unsealed source therapy. Unlike in brachytherapy, patients will also experience less 
discomfort during treatm ent sessions and will not be contaminated. External beam 
radiotherapy is the most widely used method of cancer treatm ent and is generally 
given to all types of cancer patients depending on the type and stage of cancer. EBRT 
can be delivered in many forms, namely, conventional, stereotactic radiation, particle 
therapy and advanced imaging technologies using 3D-virtual simulation for treatm ent 
(3-dimensional conformai radiotherapy (3D-CRT), intensity modulated radiotherapy 
(IMRT), image-guided radiotherapy (IGRT)). For the purposes of this research the 
focus is confined to EBRT treatm ent methods.
1 .3 .4  T rea tm en t P la n n in g  an d  T rea tm en t D e liv ery
The radiotherapy treatment process primarily consists of two stages, namely, treatm ent 
planning and treatm ent delivery. The core objective in the treatm ent planning phase 
is to find treatm ent parameters that will maximise the treatm ent effect in the target 
region while reducing potential complications in the normal tissue surrounding the 
tumour. In the treatm ent planning phase, typically, a computed tomographic (CT) or 
magnetic resonance imaging (MRI) scan over the region of the tumour, is acquired for 
the radiation oncologist to determine the stage of the tumour and plan a treatm ent
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delivery dose over the next few weeks (also known as fractionated treatment). The 
first step is to delineate the volume margins around the target tumour volume. These 
volume margins contain the tissue volumes tha t will potentially be irradiated to a 
specified dose. These volume margins usually account for some level of expected motion, 
expected variations in shape and size and also the variations in treatm ent set up, and 
therefore, need to be large enough to ensure coverage of the target [20].
D elineation  o f Tumour M argins
A radiation oncologist will delineate the palpable or visible/demonstrable extent of the 
malignant growth of the targeted tumour on the acquired CT image, called the gross 
tum our volume (CTV) [2, 20, 84, 87, 88]. Thereafter, accounting for any suspected 
microscopic spread the clinical target volume (CTV) margin is obtained [2, 84, 87, 88]. 
Finally, CTV margin is extended to account for geometric errors such as averaging or 
blurriness, due to intra-fraction motion^, inter-fraction motion^ and set up errors, the 
planning target volume (PTV) margin is delineated, to which the dose is finally pre­
scribed [2, 84, 88]. Since, many advances in medical imaging technologies have emerged 
during the last few years, target volume positions are now easier to measure, their ac­
curacy increased and measurements are taken more frequently for individual patients 
as opposed to previous methods of determining the margins, as it required according 
to [87], to accommodate a population of patients in order to estimate a margin. There­
fore, the inter-fraction errors, set-up errors will be negligible and would just take into 
account the geometric errors (intra-fraction, measurement and correction errors) [87]. 
The volume tha t encompasses the aforementioned margins (isodose surface) represent­
ing the planned minimal target dose is known as the treated volume (TV). The tissue 
volume tha t receives the dose in reality is considered to be the irradiated volume (IrV) 
[87]. The treated volume along with the CTV, CTV, PTV margins and the irradiated 
tissue volume is illustrated in Figure 1.5.
^occurs within a treatment session such as respiration 
^occurs between treatment sessions
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Figure 1.5: Schematic illustrating the process of treatm ent planning: (a) CT image 
illustrating the tumour on the right lung and is used as reference to delineate the target 
volume margins, (b) Zoomed in on the area where target volume margins are delineated 
to show the CTV (red line), extending for microscopic spread CTV (green line) margin, 
and finally PTV (yellow line) accounting for intra-fraction errors and to which the dose 
is prescribed. Treated volume margin (purple line) and finally the irradiated volume 
margin in (blue line) according to the ICRU report 50 [84]. [Note: CT image tha t was 
used to delineate was obtained from patient 1 of POPI [123] data set].
1 .3 .5  L im ita tio n s
Involuntary internal motion such as respiratory motion is one of the primary causes of 
tumour motion in the thorax and abdomen, which creates limitations in the treatm ent 
planning phase. Current practices require patients to perform shallow breathing or 
free breathing during the scan process (treatment planning) and treatm ent delivery 
phases. This gives rise to limitations in image acquisition, treatm ent planning and 
treatm ent delivery phases. In conventional radiotherapy procedures, internal motion 
(respiration) if not accounted for, will cause artifacts tha t would distort the target 
volume and give incorrect positional and volumetric information as it will be difficult 
to delineate the boundaries of small mobile volumes that are potentially cancerous [20]. 
In the treatment planning phase, it is important to account for tum our motion due 
to respiration, therefore, the volume margins need to be sufficiently large. Figure 1.6
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illustrates the full motion path of the tumour during a single breathing cycle. Therefore, 
in reality the entire tumour motion limits need to be taken into account in order to 
predict the exact dosimetry for the patient. This may lead to increased radiation field 
size and consequently increase in the volume of healthy tissue exposed to the radiation. 
Finally, in the treatment delivery phase, an averaging or blurring of the static dose 
distribution over the path of motion will occur if respiratory motion is not accounted 
for [20]. Consequently, there will be a displacement between the intended and delivered 
dose distributions (also known as hysteresis). Therefore, it is of utmost importance to 
account for any limitations at any stage of the treatment procedure.
F R E E  B R E A T H IN G
Figure 1.6: Illustration of the full motion path of the tumour and its margins due to 
respiration.
Radiotherapy treatm ents when given both externally and internally to the patients, can 
be classed as therapeutic (curative), prophylactic and palliative radiotherapy. Ther­
apeutic (radical) radiotherapy focuses on destroying the tumour. Prophylactic radio­
therapy is to stop the cancer growing in the same area after surgery and to reduce 
metastasising to other organs. On the other hand palliative radiotherapy is used for 
lessening pain or reducing the size of the tumour. Palliative treatment is usually of 
lower doses than therapeutic radiotherapy and is given over a shorter period of time. 
Typically, the amount of radiation dose delivered is measured in gray units (Gy) and 
varies between the type and stage of the cancer being treated. For therapeutic cases 
such as lymphoma are treated typically with a dose of 20 to 40Gy, while for epithelial 
tum our the dose would be in the range of 60 to 80Gy [121, 123]. Delivery parameters 
for a prescribed dose are determined during the treatm ent planning phase. Depending
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on the stage and type of cancer these prescribed doses can be spread out over a period 
of time (or fractionated).
1.4 State-of-the-Art Imaging and Guidance
Among much advancements in radiotherapy two of the salient advancements are, first, 
the availability of imaging in the treatm ent room, allowing improvement to  the delivered 
treatm ent accuracy of ±3mm. Second is the development of respiratory correlated 
imaging, providing patient specific respiratory motion for treatm ent planning, among 
which the leading image techniques are 4-dimensional computed tomography (4DCT) 
and cone-beam computed tomography (CBCT).
One of the earliest, most common treatm ent methods is the conventional radiotherapy 
also known as 2-dimensional external beam radiotherapy (2DXRT), A single beam of 
radiation is delivered in difierent directions to the patient. The main advantage of using 
conventional method is th a t since the radiation delivery is planned or simulated on a 
specially calibrated diagnostic x-ray machine known as a simulator because it recreates 
the linear accelerator actions in order to accurately target and localize, it is considered 
to be quick and reliable. However, the main disadvantage of this method is th a t the 
actual treatm ent volume margin is much greater than the target tum our volume itself. 
Therefore, volume of radiation exposure of normal healthy tissues surrounding the 
tumour is greater.
Proton therapy is another interesting method of EBRT, where energetic ionizing parti­
cles such as protons or carbon ions are directed at target tumour. The radiation dose 
increases while the particle penetrates the tissue reaching the Bragg peak which is the 
maximum limit tha t occurs near the end of the particle’s range and drops to almost a 
zero value [20]. The main advantage in this method is the amount of normal healthy 
tissue exposure to less radiation.
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1 .4 .1  V ir tu a l s im u la tio n  
3D-Conform aI R adiotherapy
One of the most common external beam radiotherapy methods is the three dimensional 
conformai radiotherapy (3D-CRT). 3D-CRT uses highly innovative computer software 
and advanced treatment machines to deliver radiation to very precisely shaped target 
areas [121]. 3D-CRT uses a multi-leaf collimator (MLC) to conform the shape of the 
tum our and deliver the radiation dose. Thus, this computer-guided method delivers 
high-dose radiation with relatively fewer side effects.
In tensity  M odulated  R adiotherapy
W ith the recent advances medical imaging technologies, a widespread technique is 
the high-resolution intensity-modulated radiation therapy (IMRT), which is sometimes 
called three-dimensional IMRT (3D-1MRT), and uses a multi-leaf collimator (MLC) as 
well. During this treatment, the patient breathes normally while receiving a 4DCT 
gated acquisition where, the layers of the multi-leaf collimator are moved while the 
treatm ent is being given. This method is able to shape the profile of the treatment 
beams very precisely and allows the dose of external radiotherapy to be altered in 
different parts of the treatm ent volume. The main goal in IMRT is to increase radiation 
dose to the tumour volumes while reducing the radiation exposure to specific sensitive 
volumes surrounding the normal tissue. IMRT has fewer side effects when compared to 
traditional external 3D conformai radiotherapy (3D-CRT) treatment, such as damage 
to  the salivary glands which can cause dry mouth when head and neck are treated with 
IMRT [121].
Im age G uided R adiotherapy (IGRT)
Image-guided radiotherapy is a widespread radiotherapy treatm ent method as it pro­
vides the tools needed to manage both inter- and intra-fraction motion to improve 
the accuracy of radiation field placement during treatment delivery [50]. IGRT uses a 
technique called ’’gating” which is an electronic method of limiting the effect of normal
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intra-fraction motion. Gating enables the radiation beam to selectively treat a moving 
tumour by turning the beam on/off at specified intervals [72, 93, 94]. One of the salient 
features of IGRT is th a t it takes into account of all the possible set up errors, patient 
immobilization, e tc ... during treatment.
1.5 M otivation
Motion between image frames (CT or PET or MRI) during one radiotherapy session, 
also known as intra-fraction motion has become a crucial issue in image guided radio­
therapy. Intra-fraction motion can occur due to motion in respiratory, skeletal mus­
cular, cardiac and gastrointestinal systems [20]. However, this research will focus on 
intra-fraction motion caused due to the respiratory system as it is one of the most 
common problems occurring in external beam radiotherapy procedures. The tum our 
motion induced by patients free breathing during treatm ent delivery limits the accu­
racy of radiation dose delivered to the target. This will lead to systematic dose delivery 
errors, damaging not only the cancerous cells but also the healthy cells surrounding the 
tumour in a patient, as opposed to 3-dimensional conformai radiotherapy (3D-CRT), 
where the beam is shaped to conform to the shape of the target while limiting the dose 
delivered to the organs at risk. In order to  achieve the goal of normal tissue sparing, 
a patient needs to lie still while the treatm ent is in progress. However, if any patient 
movement is detected it could cause undesirable ambiguities in the location of the tu ­
mour. In contrast to previous literature, where assumption is made th a t the external 
markers and thoracic/abdominal surface moves in unison with the tum our motion, this 
research will study the parameters of the patient’s actual breathing motion and will 
build a parameterised spatio/tem poral motion model. Another common problem is the 
radiation beam delay or latency due to system [85]. The delay in the time needed for 
the radiotherapy machine to move the head and produce a beam profile tha t conforms 
to the treatm ent plan at a particular angle. This means that the patient’s internal 
organ configuration needs to be dynamically predicted in order to minimize treating 
normal tissue at the tumour margin [58].
The treatm ent planning phase, is essentially assuming a stationary anatom y[20, 85, 54].
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Organ motion will result in a deviation of the delivered dose from treatment plan. If 
not accounted for, such organ motion due to respiration, can lead to an under-dose 
of tum our or overdose of the surrounding tissue [61]. By defining a patient specific 
motion model, the organ motion of the anatomy of interest due to respiration will be 
described, and in a more general context is assumed tha t the motion model is capable of 
facilitating the respiratory-induced motion. Thus, accounting for motion will improve 
the effectiveness and efficiency of the radiotherapy treatment.
1.6 Proposed M ethod
In this research therefore, emphasizes in reducing the planning target volume (PTV) 
margin for radiotherapy procedures. Figure 1.7 illustrates the grand schematic for the 
overall problem of reducing the PTV margin. First stages of treatm ent planning will be, 
to obtain dynamic CT (upto ten volumes or one full breathing cycle), which is initially 
obtained through a digital phantom called XCAT, (which will be explained in detail in 
a later chapter) tha t can be made to represent the organ motion as it appears in CT in a 
rather idealised manner. This method will later use dynamic CT of real patient data to 
obtain a valid motion model. The motion model is perturbed for changes in breathing 
cycle accordingly, as individual characteristics of breathing (quiet/shallow vs. deep, 
chest vs. abdominal, etc..) and motion variations associated with tumour location 
and pathology could lead to distinct individual patterns in displacement, direction and 
phase of tumour motion. This is achieved by using iterative registration methods [10] 
to determine the transformation parameters in order to localise the tumour and various 
organs’ motion (OAR) at different phases, and from this infer tumour motion. It is 
im portant to note the following were assumed in this case;
• the organs behave in a piecewise affine motion,
• tha t no movement occurs due to digestion,
• the breathing is consistent throughout the scan.
Therefore, with the aid of registration algorithms a parametrised tumour volume could 
be obtained and the tumour position could be determined. This method is also concomi-
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tant in finding the correlation of motion between the lung tum our and internal/ external 
surrogates. The correlation model between the lung tumour and the surrogates allow 
to observe tha t the tum our volume could be targeted within ±3 mm from the CTV - 
PTV  margin in any direction which accounts for geometric errors in treatm ent planning. 
Consequently, reduces the overall PTV  margin of error in tum our motion considering 
imperceptible penetration, with a standard deviation of ±1%, which leads to reduced 
patient dose delivery in the treatm ent plan, where significant normal tissue sparing 
could be gained.
1.7 Outline of Thesis
The first chapter discusses briefly about the radiotherapy procedures, methods tha t are 
currently in use and also the margins and the treatm ent plans and their methods of 
delivery. It also details the state-of-the-art imaging technologies th a t are being used to 
treat patients. The second chapter discusses in depth the physiology and the breathing 
mechanics to help understand the different patient models. It also reviews the different 
respiratory motion management methods tha t are currently in use.
The third chapter details the key points of extracting the respiratory-induced motion 
from four dimensional computed tomographic (4DCT) data. The iterative registration 
methods in specific, ICP algorithm was used to help extract this motion. This data 
was both in the form of simulated and clinical data sets. The fourth chapter discusses 
respiratory-induced motion correlation model. It details the parameters th a t were used 
to build the correlation model and how it will be implemented. This also examines the 
preliminary results of the correlation model. Next chapter implements the proposed 
respiratory correlation model on the clinical data sets tha t was obtained via the CRE- 
ATIS labs in France. This analyses the feasibility of the proposed method. Finally, the 
last chapter briefly discusses the outcomes and possible future work.
1.8 Achievem ents
The work carried out in this research was awarded the lE T  Innovation Award in 2012.
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Figure 1.7: Schematic representation of the proposed method. A dynamic CT volume 
will be used to parameterise the tumour location and subsequently tumour motion is 
observed in order to determine the tumour motion pathway with respect to the patient’s 
breathing pattern. This is then used to determine the entire tumour motion path and 
subsequently reduce the PTV margin for dose delivery.
Chapter 2
Respiratory-induced Tumour 
M otion and M otion M odelling in 
Radiotherapy
Imaging is the first step in the treatm ent stages of radiotherapy. When imaging (CT 
or MRI), distortions occur due to involuntary movements such as breathing and will 
subsequently lead to erroneous dosimetry tha t could be undesirable to the patient. 
Specifically, in the planning stage where delineation of target tum our volumes and the 
localisation of adjacent normal structures tha t determine the patient dosimetry are 
carried out. This motion however, as in all cases will depend greatly on the location of 
the tumour and the region tha t the given motion is affected. Respiratory-induced intra­
fraction motion  ^ is a budding problem in the treatm ent planning and delivery stages in 
radiotherapy procedures. Initially, the treatm ent planning and delivery were developed 
as static processes, in which the intended treatm ent plan would be delivered only if the 
tumour was stationary at the beam isocenter. Thus, internal motion in patients causes 
inaccurately aiming the radiation beam to the targeted lesion, leading to erroneous 
detection and tracking of thoracic malignancies (tumours) in the treatm ent planning 
stage. This positional uncertainty due to respiration is inherent in radiotherapy, and
^Intra-fraction motion is motion that occurs within one session. Inter-fraction motion is motion 
that occurs between sessions.
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the prevailing method according to the ICRU report 50 [84] is to irradiate a volume 
larger than the target. Consequently, the radiation dosimetry for the tumour in the 
treatm ent delivery stage can potentially be harmful to the patients as it will harm any 
healthy tissues surrounding the tumour. Therefore, it is important to account for any 
internal target motion that is induced by respiration, that occurs during treatment 
planning and delivery.
This chapter will look at the physiology of respiration, respiratory-induced motion in 
radiotherapy, the specific problems tha t are arisen due to respiratory-induced motion 
and techniques that account for the aforementioned respiratory-induced motion.
2.1 Physiology of the Respiratory System
Anatomically, the respiratory system can be classified according to structure and func­
tion. Structurally, the respiratory system consists of the upper respiratory system that 
includes, nose, pharynx and associated structures and lower respiratory system tha t in­
cludes the larynx, trachea, bronchi and lungs [119]. The respiratory system’s function 
can also be further subdivided into two categories, namely, the conducting zone which 
consists of interconnected cavities and tubes that filter, warm and moisten air that 
will be conducted to the lungs later and the respiratory zone consisting of lung tissue 
responsible for the gas exchange (explained in greater detail later in the chapter).
2.2 M echanics of Respiration
Respiratory motion is, an involuntary internal motion that allows the lungs to facil­
itate its cardinal function of the exchange of oxygen (O2 ) and carbon dioxide (CO2 ) 
between blood and air in the body. As illustrated in Figure 2.1 gas exchange occurs 
in the respiratory zone due to diffusion between the alveoli and the blood in lungs’ 
capillaries [119, 128, 131]. When the dissolved gases have entered the blood stream the 
heart will carry the essential gases to the vital organs via the circulatory system. Al­
though, respiratory motion is involuntary and is not rhythmic as the heart, frequency
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Figure 2.1: Illustration of the anterior view of the structure of the respiratory system 
[53]
and magnitude of the respiration can be controlled within limits, as well as breath- 
holds [20]. Respiratory motion patterns are categorized according to posture (upright, 
prone, supine, lateral decubitus), breathing types (chest or abdominal) and depth of 
respiration (shallow , normal, deep)^ [20, 53, 112, 119].
Figure 2.2 illustrates the typical breathing mechanics of the lungs during a normal 
respiratory cycle.
2 .2 .1  In h a la tio n
Lungs are held in the thoracic cavity encased by the liquid filled intra-pleural space 
[20]. During quiet breathing^, respiratory muscles around the lungs actively participate 
in the process of breathing. It is however to be noted, tha t the principle muscle during 
inhalation is the diaphragm and is dome-shaped, concave towards the abdomen [128]. 
Other respiratory muscles that connect the adjacent ribs such as external intercostal
^Normal pattern of quiet breathing is called eupnea. Eupnea can be shallow, deep or combined
shallow and deep breathing. Shallow breathing is also known as chest breathing, normal breathing is
also known as costal/tidal breathing or normal resting breathing and deep breathing is also known as
diaphragmatic breathing [119]
^Due to the fact that majority of the air is drawn into the lungs during quiet breathing is considered
as opposed to other types of breathing patterns.
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F ig u re  2.2: Physiology of typical healthy lungs during inhalation [29].
muscles, slope downward (interiorly) and forward (anteriorly). During inhalation the 
volume of the thoracic cavity increases and air is drawn into the lungs. As illustrated in 
Figure 2.2, the volume of the thoracic cavity increases partly due to the contraction of 
the diaphragm, which causes the diaphragm to push downwards (interiorly) causing the 
abdominal organs to descend as well as move forward (anteriorly), and partly due to 
the external intercostal muscles that raises the ribs upwards (superiorly) and anteriorly, 
thus increasing the cross-sectional area of the thorax both in the lateral and anterior- 
posterior (AP) direction. Subsequently, this reduces the intra-thoracic pressure that 
allows air to be drawn into the lungs through diffusion [20, 128].
2 .2 .2  E x h a la tio n
During quiet breathing expiration, it is considered to be passive as it is considered to 
be at equilibrium or at the most relaxed state. Lungs are generally elastic, therefore, 
returns passively to its preinspiratory volume during resting breathing and is easily dis­
tended. The principle muscles during exhalation are those of the abdominal wall which 
include the rectus abdominus, internal and external oblique muscles and transversus 
abdominus [128]. During exhalation, as illustrated in Figure 2.2 the volume of the
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thoracic cavity decreases with the aid of internal intercostal muscles pulling the ribs 
interiorly and inwardly (posteriorly). The intercostal muscles tighten as well in order to 
avoid the ribs from bulging outwards. Other external factors such as controlled breath­
ing in yoga, exercise, e tc ... will have considerable effect in increasing the exhalation 
process.
However, it is to be noted the inflated volume of the lung at inhalation is considerably 
smaller than the deflated volume of the lung at exhalation'^ during a breathing cycle. 
This asymmetry in respiration is well-known as hysteresis.
2 .2 .3  H y ste r e s is
Hysteresis in respiration is a common occurrence in the lungs due to  the aforementioned 
asymmetric nature of a breathing cycle. Typically, two simultaneous projection images 
at oblique angles are required to locate a tumour in 3-dimensions. However, the tum our 
may not always follow the same trajectory at all times [107]. This phenomena is called 
hysteresis. Realistically, occurrence of hysteresis is to be expected and is calculated the 
maximum distance as the inhalation and exhalation trajectories. Although, different 
metrics have been proposed for measuring the maximum distance such as Hausdorff 
distance, Prechet distance in majority of the cases the maximum euclidean distance 
has been considered the basis for calculating hysteresis.
Previous literature discusses the quantification of hysteresis and the non-linearity of 
respiratory motion when estimating or predicting or tracking respiratory motion or 
building respiratory motion models [13, 20].
As illustrated in Figure 2.3, the shape of the trajectories curve remains fairly constant 
in time. Previous literature also discusses tha t the average tumour position is the most 
stable and reproducible during exhale phase of tidal breathing [107, 112].
The deflated lung volume at the end of exhale is also known as functional residual capacity
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2.3 Respiratory M otion in Radiotherapy
As previously explained, imaging as the first step in the treatm ent process of radiother­
apy. Imaging technologies such as CT and MRI studies provide geometric information 
in the treatm ent planning phase to delineate the gross tumour volume (GTV) mar­
gins and to  localise any adjacent organs-at-risk (OAR). This obtained geometric data 
will then be used in the planning process to orient the beams to encompass the target 
volume while sparing any normal tissues surrounding the tumour. In CT particularly 
information on tissue densities, tha t help calculate the dosimetry for radiation, will 
also be provided. Chen and Reitzel [21], explains that unlike in diagnostic scans, in 
treatm ent planning scans in the thorax and the abdomen are often performed with 
the patient breathing ’’lightly” . This is performed so that the patient breathing is kept 
consistent during the scanning and treatm ent delivery. Organs in the thoracic-abdomen 
region move almost periodically along the cranio-caudal^ and anterior-posterior (AP) 
directions during respiration. In [56], describes the amplitude of this motion is on the 
order of centimeters with a period of ~4s.
It is im portant to note tha t in the treatm ent stages of radiotherapy, a static anatomy 
is assumed when delineating the tumour margins and the intended plan for the patient 
dosimetry would be delivered only if the tumour is stationary at the beam isocenter.
^sometimes depending on the scanned anatomy also referred as the superior-anterior (SI) direction
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Treatment sites can move under a variety of physiological influences, both stochastic 
and deterministic (i.e., regular, systematic and periodic) [85]. This motion would gen­
erally lead to erroneous expansion of the treatm ent margins and dose deliveries th a t 
encompass the range of motion due to respiratory-induced intra-fraction target (tu­
mour) motion (during a single fraction of treatment) or inter-fraction motion (different 
fractions over the treatm ent plan).
Although, many studies [40, 41, 92, 106, 107, 114] have been carried out for determining 
the magnitude and type of variation in intra-fraction variation in respiratory motion 
the results of these studies have proven inconclusive. One major problem according to 
[80], is the difficulty in imaging the internal respiratory motion for the time taken to 
deliver a fraction of treatm ent several minutes later. Currently well-designed margins 
are considered to deliver intended high radiation doses to the target, whilst destroying 
healthy tissues surrounding the tumour. Thus, inaccurate projection of the range of 
intra-fraction motion of the target will result in any inaccurate dose delivery. Therefore, 
in order to better deliver efficient radiation doses to patients, well-designed margins 
need to be adaptable and possibly compensate any target motion during treatm ent 
sessions. To adapt and compensate, for any form of motion in the target, in this case 
the lung tumour, will take time. Therefore, in order to account for any time delays 
between determining the tumour position or tumour localization and the response time 
would require tumour motion prediction.
Figure 2.4 illustrates the key components typically to consider when compensating 
for the aforementioned target motion, particularly, respiratory-induced intra-fraction 
motion. In the motion estimation phase, given any breathing pattern, estimation of 
the current location of the tumour in the thorax or tum our localization is carried out. 
Typically, image registration methods and regression methods are used for this purpose. 
Once the current tumour position is localized then this information is used to predict 
the tum our’s next feasible position in the breathing cycle. Thus, with the predicted 
position a correlation model can be built, with the aid of external markers and/or 
using a surrogate organ, to compensate the target motion. Thus, planning volume 
target (PTV) margin can be reduced and consequently patient dose will be reduced as 
well as normal tissue sparing will also be achieved.
24 Chapter 2. Respiratory-induced Tumour Motion and Motion Modelling in
Radiotherapy
Motion
Compensation
Motion
Estimation
Motion
Prediction
hedictnext 
phase of the 
bieatliiiig cycle
Tiuiioiir
localization
Compensate for 
timionr motion 
for each patient
Estimate ciment 
position in 
breatliing cycle
PTV^  margin 
reduction and 
dose contr ol
F ig u re  2.4: Stages of motion compensation
Unlike inherently unpredictable stochastic motion, deterministic motion such as respi­
ration follows a trajectory tha t can be tracked and the tumour position can be known 
continuously. Thus, within reason the tumour motion can be predicted with confidence 
and accuracy. Therefore, as explained in [85], in such situations, synchronous move­
ment between the beam and the tumour or, gating the beam on/off as the tumour 
moves in and out of the line of sight is possible.
However, malignancies in the thoracic and abdominal regions in particular, are prone to 
target motion (organ and/or tumour) caused due to intra-fraction internal respiratory 
motion. Therefore, during the treatm ent stages, this mitigating circumstance of organ 
and tumour motion need to be accounted for, in order to deliver doses to patients more 
effectively and efficiently. If these mitigating circumstances are not properly managed it
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may lead to undesirable ambiguities (such as blurriness in the acquired scanned imaged, 
distortion of the tum our volume and shape, e tc ... ) in both the treatm ent planning 
and delivery stages hindering the expected outcome for the patient. This is crucial in 
the treatm ent planning stage as the acquired diagnostic (scanned) images (CT, MRI, 
e tc ... ) are used to  quantify the tumour margins and consequently this information 
is used in the treatm ent delivery stage where the patient is treated with high energy 
radiation. Thus, during treatm ent delivery stage overdose of the tum our subsequently 
leading to an increase in destroying healthy tissue surrounding the tumour, or underdose 
of the tumour th a t would allow the rapid growth of the tumour cells and thus could 
potentially be fatal for the patient. Therefore, it is of utmost importance to account 
for respiratory-induced motion in the thoracic and abdominal regions in all stages of 
radiotherapy.
An adaptive treatm ent system to be effective needs to respond to  the motion in real­
time. The process of adapting to respiratory motion in radiotherapy can be divided 
into four tasks:
• observing and assessing the anatomical motion
• devising a treatm ent plan tha t accommodates respiratory motion and takes ad­
vantage when needed
• identifying tum our position at a given time point
• performing beam alignment response synchronous to the motion (coordinated 
with the treatm ent plan)
2 .3 .1  M ea su r in g  R esp ira to ry  M o tio n
Respiratory-induced motion largely affects organs in thorax and abdominal areas by dif­
ferent degrees and ways. Although, lungs, heart, liver, chest wall, diaphragm, e tc ... will 
pre-dominantly show respiratory-induced motion, it has been previously shown by 
[61, 107] tha t lung tumours exhibit a motion of >  3 cm in the cranio-caudal direc­
tion during normal respiration whilst, other organs show a minimal motion if not at
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Figure 2.5: Illustration of the coronal views of the aforementioned blurriness of the 
acquired diagnostic images from the same patient due to respiratory induced motion 
in the thoracic and abdominal region during free breathing and gating [20].
all in some cases. It is however to be noted that measuring respiratory motion will not 
solely be based on only the organs that are affected by breathing. Target (tumour) 
motion will depend primarily on its location and the fixation of the organ.
However, lung cancer patients often find it difficult to breathe as a normal patient 
therefore causing motion that is not significantly large enough to measure. Keall et 
al, 2006 [61] have carried out a study over a population of patients tha t approximates 
the median lung tumour motion to be around 5 mm in the cranio-caudal direction. 
Thus, often causing blurry low contrast imaging as shown in Figure 2.5. Typically, the 
acquisition of a CT scan is taken on the same scale as that of the patient’s respiration. 
Acquisition of single CT slice takes about 0.5 - I s ,  while a respiratory cycle will last 
for about 3 - 6 s [61]. Therefore, organ and overall structure of the organ move both 
during the slice acquisition thereby creating artefacts which eventually also leads to the 
cause of acquiring blurry CT images. Blurring usually occurs when the slice acquisition 
time is longer than the respiratory cycle [20]. As previously explained in slow CT scans 
although slice acquisition time is prolonged, images represent average organ positioning 
also causing blurry images. This however, makes the delineation process more difficult.
Respiratory motion can be measured directly by measuring the tumour motion, or in­
directly measuring the motion of a surrogate organ (diaphragm or lungs or liver or any
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other organ tha t moves with respiration) or the motion of the external fiducial mark­
ers. However, measuring motion in each individual patient largely relies (as explained 
previously) on the manner the patient breathes. Therefore, it is im portant to identify 
individual breathing pattern before treatm ent begins.
As illustrated in Figure 2.7 breathing patterns of patients differ from magnitude [38, 
112], phase [36, 38, 127], period and regularity of imaging and treatm ent sessions [20]. 
The following summarises the 3D tum our motion data properties as seen in Table 2.1, 
with any dominant directions shown in bold font.
P atient D uration(s) C ycle X  am plitude Y  am plitude Z am plitude
D uration (s) and std. dev (m m ) and std. dev (m m ) and std . dev (m m )
PI 292.67 3.60±0.31 2.784:0.26 9.574:0.78 10.404:1.03
P2 178.20 4.79±1.38 2.854:0.75 9.534:3.50 4.404:0.99
P3 187.17 5.034:1.34 25.624:3.55 6.654:1.36 9.784:3.07
P4 141.90 2.614:0.27 3.854:0.40 13.454:0.92 4.344:0.47
T ab le  2.1: Summary of the 3D tum our motion data properties with dominant motion 
shown in bold where X,Y and Z correspond to the right-left, superior-inferior and 
anterior-posterior orthogonal directions of motion, respectively [58].
Previous literature discusses the aforementioned respiratory-induced motion, having 
been detected and measured on different modalities such as ultrasound [27], ffuo- 
roscopy [32], computed tomography (CT) [110], 4-dimensional computed tomography 
(4DCT) [78], magnetic resonance imaging (MRI) [68], cone-beam computed tomogra­
phy (CBCT), 4-dimensional cone beam computed tomography (4D-CBCT).
Shirato et al, 2004 [112] explains, the insertion of gold fiducial markers near or into 
lung tumours to measure motion. It records amplitudes of intra-fractional lung tum our 
motion during normal tidal breathing, showing an increase in the motion in the SI 
(superior-inferior) direction with a range of 0.2 - 24.6 mm. Although, it is to be noted 
tha t each patient breathing pattern as previously shown is different therefore the range 
of the motion can depend on each individual characteristic. Although, it has been 
argued in [38] tha t no correlation has been reported between the amplitude of the 
tumour motion due to respiration and patient characteristics such as height, weight.
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(a) Direct tumour measurement
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(c) The surrogate organ
Figure 2.6: Illustration of the various measured observables used to measure
respiratory-induced motion, (a) Lung tumour motion (b) surface render of the ex­
ternal thoracic markers on a patient, (c) The surrogate organ is the bottom of the lung 
and the tumour is illustrated in green.
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F ig u re  2.7: Illustration of partial Cartisian traces of three-dimensional tum our respi­
ratory motion in four different patients as explained in [58].
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age, e tc .. . .
Seppenwoolde et al, 2002 [107], also describes extensively markers implanted near or 
into the tumour to monitor the tumour motion using dual real-time fluoroscopic imag­
ing methods to measure the 3-dimensional trajectories. According to [107], since the 
tum our motion spends longer period in the exhalation rather than the inhale position 
the time averaged tumour position was closer to the exhale position. Shimizu et al, 
2000 [109], carried out a study that showed the invisibility of the tumour location.
2.4 Respiratory-induced M otion M anagement
In order to account for the aforementioned respiratory-induced motion current medical 
imaging technologies carry out motion management techniques such as, gating, breath- 
hold, e tc ... which will be further discussed later in the chapter. These techniques 
occur at different stages of the radiotherapy procedures treatment planning, quality 
assuarance are to name a few.
2 .4 .1  T rea tm en t P la n n in g
One of the conspicuous stages of motion management occurs during radiotherapy treat­
ment planning stage. Senan et al [104, 105], discusses the importance of treatment 
planning for lung cancer radiotherapy and defining the tumour margins such as GTV, 
CTV, and more importantly accounting for geometric uncertainties through the (CTV- 
PTV) margin [54, 85]. When considering the target motion, the effect of all geometrical 
uncertainties is a displacement of the target during treatment relative to the dose distri­
bution determined from the treatm ent plan. However, during the treatment planning 
session target is assumed to be static and the dose distribution as a mobile structure. 
This allows the dose distributed to be summed over the time period of all fractions. 
W hen there are many fractions the random errors can be accurately described as a 
blurring of the dose distribution [74]. The blurring is approximated as a convolution 
of the dose distribution with the probability distribution function of the total displace­
ment vector of the target versus the treatm ent machine [20, 77, 81]. However [24] has
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shown tha t a convolution is not completely correct to  describe the dose changes but 
correct in practice.
Systematic errors however, should not be accounted for in this manner which makes 
pretreatm ent procedures and frequent monitoring during treatm ent particularly impor­
tant.
2 .4 .2  Q u a lity  A ssu ra n ce
Typically, quality assurance is im portant when considering external markers to monitor 
in gated or breath-hold treatm ent procedures with its level of accuracy used in the 
monitors to predict internal target-organ position. This is crucial as transient changes 
in respiration can cause interference in the internal-external position correlation [20]. It 
is im portant tha t the patients familiarize themselves with the breathing technique and 
evaluating the ability to achieve reproducible respiratory signals. Therefore, specially 
trained staff is essential and they will be properly trained to coach and advise the 
patients.
Some motion management techniques require additional devices th a t may come in 
contact with patients and thus, needs to practice proper hygienic quality assurances for 
safety. It is also important to note when equipment used in the treatm ent procedure are 
properly tested and their limitations in each case should be understood. Thus, avoiding 
any issues tha t may potentially arrive during treatm ent and needs to  be corrected in a 
timely manner [20].
2.5 EBRT M ethods Accounting for Respiratory-induced  
M otion
As previously explained most methods do not explicitly account for involuntary mo­
tion such as respiration during treatm ent procedures. However, with the increase in 
medical imaging technologies, methods tha t take into account the aforementioned issues 
accounting for respiratory-induced motion during treatm ent can be broadly categorised
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into 5 main categories, namely, motion-encompassing methods, respiratory gating tech­
niques, breath-hold techniques, forced shallow breathing techniques and respiration 
synchronised techniques [85].
2 .5 .1  M o tio n  E n co m p a ssin g  M e th o d s
These methods take into account tha t motion due to respiration exists during radiation 
delivery and estimates the mean and range of motion during the CT imaging. The three 
main techniques tha t adapt these conditions are, in order of increasing workload, slow 
CT, inhale and exhale breath-hold CT and finally 4-dimensional (4D) or respiratory 
correlated CT. Since the transient changes in tumour motion occurs during simulation 
and treatm ent sessions, it is im portant to understand the breathing patterns. Hence, 
the radiation dose for patients tha t undergo this treatm ent method may have a greater 
dose than standard CT simulation procedures by a factor of 2 to 15.
Slow CT Scanning
Slow CT scanning is typically used when obtaining representative CT scans for periph­
eral lung tumours [73]. In this technique, the CT scanner is operated very slowly, and/or 
multiple CT scans are averaged such that multiple respiration phases are recorded per 
slice. Since this is an easily available option on majority of the CT scanners, the tu ­
mour should show the full extent of the respiratory motion during the time of the 
scan, provided tha t the scanner operates at a particular couch position for longer than 
the respiratory cycle. Additional margins will be required as this technique yields a 
tumour-encompassing volume which varies during imaging and treatm ent delivery due 
to  the limitation of the varying respiration during the entire treatm ent procedure.
One of the many advantages of slow CT scanning is dose calculation is more represen­
tative of the actual tumour volume of the entire respiratory cycle, thus, more accurate 
anatomic delineation occurs during treatment. Another advantage would be, the over­
all treatm ent process does not increase in complexity over tha t of free-breathing CT 
scan since only one CT scan is obtained [54].
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The main disadvantage is the loss of resolution due to motion blurring. This can 
lead to bigger margin errors due observer errors causing tumour and healthy organ 
delineation. Due to this reason slow CT scanning is not the optimal method for treating 
as explained in [20], lung tumours tha t are not involved with either the mediasternum
or the chest wall or for any tumours in the liver, pancreas, kidney, etc  Another
notable disadvantage is the higher dose used as compared to the standard method. 
Furthermore, [86] suggests tha t with tomographic imaging such as PET, is a better 
imaging source and is better for estimating the tumour motion path due to  its inherently 
long acquisition times. However, the tum our motion can potentially blur the object 
in PET thus, the suspected lesions may not be apparent. Therefore, respiratory gated 
PET or 4D PET is a more suitable option to obtain the palpable tum our margins.
Inhale-Exhale B reath-hold  CT
During the CT simulation session in order to obtain a tumour-encompassing volume 
tha t can be implemented in most clinics is to acquire both inhale and exhale gated 
or breath-hold CT scans [6, 95] of the patient. As this encompasses CT of both the 
inhale and exhale phases it takes twice the time required to obtain one CT data  set. 
This method also depends greatly on the ability of the patient to hold their breath 
reproducibly. Breath-hold or gated CT works in a manner such th a t the radiation is 
delivered only within a particular portion of the breathing cycle also referred to as 
the ’gate’. Depending on whether the patient is spending more time on exhalation or 
inhalation phase dose will be calculated for the appropriate inhale or exhale CT data  
set accordingly [20]. One of the major advantages of using this method as opposed 
to the slow CT scanning is, any blurring tha t is caused during free-breathing would 
be significantly reduced due to breath-holding technique. Respiratory gating is often 
associated with intensity modulated radiation therapy (IMRT) to optimally deliver 
radiation doses to the tumour, sparing normal tissue surrounding the tumour.
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2 .5 .2  M o d e llin g  R esp ira to ry -in d u ced  M o tio n  to  A d a p t P a tie n t  S p e ­
cific M o tio n
Motion analysis achieves two important tasks, detecting correspondences between sub­
sequent images and tracking of an object within a sequence of images [96]. This is 
mainly based on a varied range of methodologies, such as tracking 2D features at 
a local (e.g, corners) and global level(e.g, silhouettes, after segmentation of images). 
Respiratory-induced motion modelling is based strictly on the characteristics of the 
breathing model.
One of the many assumptions that were made during this research was tha t there was 
no tum our growth occurring between treatm ent sessions or during treatment. This re­
search also assumes the tumour behaves exactly as the initial scanning session. Another 
assumption particularly for tumours growing in the abdomen, is that the inexistence 
of peristalisation
Modelling respiratory-induced motion clinically has much significance as each patient 
has a different breathing pattern, a body mass index, health issues, lifestyle that are 
all factors to be accounted for when modelling patient-specific motion models.
2.6 Summary
This chapter initially reviews the basic physiology and the mechanics of breathing. 
However, it is important to note that, breathing is a continuous process tha t although 
can be temporarily held during a treatm ent procedure it may not be comfortable for 
the patient and also may not be able to perform in accurate time intervals due to 
human error. This leads to obtaining distorted (blurry, partly visible, etc...) image 
scans of the lung tumours, thus, leads to determining inaccurate lung tumour positions 
penultimately leading to erroneous dosage and finally, treatm ent delivery. Therefore, 
current state-of-the-art radiotherapy procedures and their effects due to respiratory 
motion is reviewed and discussed. Finally, methods that might be able to compensate
’also known as muscle behaviour during digestive motion
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such effects due to respiratory-induced motion and its importance in the clinical sense 
is reviewed.
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Chapter 3
Treatment Planning: 
Respiratory-induced M otion  
Extraction
Imaging is the key stage in the radiotherapy treatm ent stages and is performed during 
the planning stage where radiation oncologists will also delineate the tum our margins 
and determine a patient’s dosimetry. Since, the CT scan has high geometric accuracy, 
and the pixel values in the CT data are used directly to transport the beam through the 
patient, optimal beam arrangement is searched to obtain a higher dose for the tum our 
[7]. A critical step in radiotherapy procedure is to localize the lung tum our in real­
time [85]. As Dieterich et al [30], explains in order to achieve ideal localization of the 
lung tumour the following properties should be fulfilled. First, it has to be sufficiently 
accurate to capture real-time motion and deformation caused by any physiological 
processes such as breathing. Second, it should be capable of imaging and localizing 
the surrounding structures in addition to the tumour. As explained in chapter 2, it is 
of utmost importance to take into account any respiratory-induced motion during the 
treatm ent stages, particularly in the planning stage as this will determine the dosimetry 
for the patient. Therefore, this chapter focuses on how to extract the aforementioned 
respiratory-induced motion from 4-dimensional (4D) CT for analysis and account for 
during the treatment delivery stage.
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Problem  statem ent: Quantification and extraction  o f respiratory-induced  
m otion.
First section of this chapter will give a detailed description of the variety of tumour 
localisation methods that are available and then 4D CT image data sets, both simulated 
XCAT and clinical data sets. These are used as the main 4D data sources for extracting 
the respiratory-induced motion. The next section will focus on segmenting the lung 
tumours and organs-at-risk (OAR) in the thoracic-abdomen region. This is performed 
as a pre-processing step for extracting the respiratory-induced motion. The registration 
of CT with CT is useful for treatment planning since it allows repeated measurement of 
the position of an organ, quantify its mobility or to update the anatomy of the patient 
during the course of treatment. In radiotherapy particularly the bony anatomy is used 
as a reference frame, since the bony anatomy has high visibility in radiographs used for 
patient positioning. An organ-wise iterative registration method [10] will be performed 
to extract the aforementioned motion. This step will parameterise the lung tumour 
motion and OAR caused due to respiration, during radiotherapy treatm ent stages of 
planning and delivery.
Figure 3.1 illustrates the schematic for extracting the respiratory-induced motion from 
the dynamic CT data sets.
3.1 Tumour Localisation M ethods
Tumour localisation can be classified into two distinct categories, direct and indirect 
methods. Direct methods require the implanted fiducial markers to be detected and 
localise the tumour. The most prevalent direct system is the kV fluoroscopy with im­
planted markers, which is commercially available [85], where they are used for treating 
lung, liver, and other tumours [107, 112]. Direct methods allow real time tumour lo­
calisation. Spherical or cylindrical gold markers are often used for this purpose [85]. 
These markers are placed percutaneously or endoscopically. However, implanting fidu­
cial markers is an invasive procedure with potential risk of infection. Therefore, many 
clinicians are reluctant to perform such invasive methods for lung cancer treatm ent as 
such a method could easily puncture the chest wall causing pneumothorax. Another
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F ig u re  3.1: Schematic representation of the proposed method for extracting
respiratory-induced motion from the dynamic CT data sets (simulated or clinical data  
sets).
disadvantage is that depending on where the fiducials are implanted, may limit the 
different sites within the lung. [85] explains furthermore, tha t a major hurdle for these 
methods is the training of the fluoroscopic data to be acquired prior to each treatm ent, 
where the clinician must define the tum our position in each treatm ent. In principal 
4-dimensional computed tomography (4D CT) can be used to simulate fluoroscopic 
images, where the tumour position has already been marked.
Indirect methods consists of using a surrogate organs to infer the spatial information of 
the tumour. These indirect surrogates can be internal such as, diaphragm, lung, liver 
or external such as, optical skin markers, body surface, tidal volume, etc... . Typically, 
the internal surrogates tend to provide more accurate information as compared to the 
external surrogates as this will mainly, depend on the patient’s anatomical structure. 
The most commonly used external surrogate is the AP motion of the abdominal surface 
[98]. However, internal surrogates are anatomical surrogates, closer the surrogate is to 
the tumour the more accurate the localisation will be, provided the surrogate can easily 
be localised. For instance, the diaphragm is a good surrogate for lower lung, liver and
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pancreas tumours. However, the diaphragm is difficult to localise as it has smaller 
volumetric detail compared to the rest of the surrounding organs. Therefore, this could 
also be harder to localise in a scanned image. A key issue for indirect methods is the 
accuracy based on the correlation of the tumour and the surrogates, is stable over the 
entire treatm ent course. This correlation will be further discussed in the next chapter.
3.2 Image Data for Respiratory M otion
3 .2 .1  4 -D im en sio n a l C o m p u ted  T om ograp h y  (4 D C T ) Im a g e  D a ta
4-dimensional computed tomography (4DCT) or respiratory-correlated CT, was pri­
marily developed for localising tumours affected due to respiratory-induced motion in 
the thoracic-abdomen regions and obtaining high-quality CT data [35, 62, 76, 90, 126]. 
4DCT can be used to determine the mean tumour position, tumour range of motion 
for treatm ent planning and the relation of tumour trajectory to other organs and to a 
respiration monitor [20]. This technique simultaneously acquires the CT data while a 
respiratory surrogate signal is used to sort out the acquired data into phases according 
to the breathing state. Each phase will be a group of respiratory-correlated 3D image 
slices tha t will ultimately represent a breathing cycle. Therefore, each phase of the 
respiratory signal defines the fourth dimension. The acquisition can be performed in 
helical or spiral mode, where the table moves in a slow constant motion while the CT 
data is acquired continuously [35] or conversely in ciné mode, where CT scanner ac­
quires the required amount of CT slices before the next gantry transition occurs to the 
next table position [90]. Figure 3.2 illustrates the helical CT image acquisitions. Pan 
et al [90], describes in detail acquiring this 4DCT data in ciné mode and is illustrated 
in Figure 3.3.
Although, 4DCT is widely used imaging technology one of the limitations of this method 
is tha t it is affected by the variations in respiratory patterns during acquisitions. How­
ever, artefacts could still be observed [20] even-though breathing-training techniques 
were developed [64].
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Figure 3.2: Illustration of the helical CT image acquisition process [16].
3 .2 .2  S im u la ted  D ata: 4D  X C A T
The 4D extended cardiac torso (XCAT) phantom, is a whole body computer model of 
the human anatomy and physiology based on NURBS^ surfaces, developed by [100]. 
Unlike in the current phantoms in CT tha t uses simple mathematical primitives, the 4D 
XCAT provides high-resolution images and an accurate representation of the human 
anatomy that uniquely combines the anatomical realism of a voxelized phantom with 
the flexibility of a mathematical phantom. Due to the unique design of the 4D XCAT 
phantom its organ shapes can be changed to realistically model anatomical variations 
and patient motion [102, 103].
Non-Uniform Rational B-Splines
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Figure 3.3: Illustration of the image scan in ciné mode and reconstruction of the 
multi-slice CT (MSCT) image data sets as described in [90]. In this diagram, four 
images are reconstructed per sample (dot) for a 4-slice MSCT and 8 samples (arrows) 
in each respiratory cycle (sinusoidal curve), where these images are obtained at regular 
intervals at each table position. For each table transition (or gantry rotation), the x-ray 
remains turned off. Finally, these slices are grouped into volumes for each similar phase 
of the respiratory signal.
M .
Figure 3.4: Illustration of the anatomy of the 4D XCAT phantom and the simulated 
chest x-ray CT images from the XCAT phantom. Coronal(top row), transaxial (bottom 
2 rows) reconstructed slices according to [102].
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A natom ical Param eters
Height 192cm
Weight 95kg
R espiratory M otion  Param eters
respiratory period 5s
max. SI motion 2cm
max. AP motion 1.2cm
pixel width 0.325cm
slice width 0.325cm
array size 128
T ab le  3.1: Anatomical and respiratory motion parameters of the XCAT phantom for 
a male
3.3 Segm entation of Organs Affected by Respiratory-induced  
M otion
Segmentation is an essential image processing technique th a t is used on structures to  
separate from background and/or from each other. This process is used as a prepro­
cessing step for visualisation and compression. Segmentation is typically achieved by 
identifying all the pixels or voxels tha t are homogeneous with one or more characteristics 
or features to the object (organ), typically by locating those tha t form its boundary. In 
medical image processing techniques segmentation is used as an im portant tool in many 
applications such as, detection of the coronary border in angiograms, multiple sclerosis 
lesion quantification, surgery simulations, surgical planning, measuring tum our volume 
and its response to therapy, functional mapping, automated classification of blood cells, 
studying brain development, detection of microcalcifications on mammograms, image 
registration, atlas-matching, heart image extraction from cardiac cineangiograms, de­
tection of tumours, e tc ... are to name a few [7, 39, 63, 117]. Although, segmentation is 
used in many of the aforementioned applications, it is mainly used for the purposes of 
feature extraction, image measurement and image display in medical images. In certain
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applications such as in image registration techniques, it is important to classify image 
pixels into anatomical regions, such as bones, muscles, tumour and other organs while, 
in others into pathological regions such as cancer, tissue deformities and multiple scle­
rosis regions. It is also important to note tha t there is no one standard segmentation 
technique tha t can provide with satisfactory results as the goal of segmentation varies 
according to each study and the type of image data. In [7] the segmentation techniques 
are categorised into many classes depending on the classification scheme. They are as 
follows:
• Manual, semiautomatic and automatic.
• Pixel-based (local methods) and region-based (global methods)
• Manual delineation, low-level segmentation (thresholding, region growing e tc ... ), 
and model-based segmentation (multispectral or feature map techniques, dynamic 
programming, contour following e tc ... ).
• Classical (thresholding, edge-based and region based techniques), statistical, fuzzy 
and neural network techniques.
However, segmentation can be divided mainly to two broad categories, namely: (1) 
region segmentation and (2) edge-based segmentation. In region based segmentation, al­
gorithms identify the homogeneous characteristics in the image pixels or voxels in data. 
On the other hand, in edge-based segmentation, algorithms find object boundaries and 
segment regions enclosed by boundaries [19]. Thresholding is the most common region 
segmentation method available. In this technique, a threshold is selected and the image 
is divided into groups of pixels having less than the threshold, greater than or equal to 
the threshold. Thresholding techniques are generally subdivided into global, local and 
dynamic or temporal thresholding [7]. Other popular region segmentation methods are 
clustering and region growing. Popular edge based segmentation algorithms are, graph 
search, contour following and gradient operators [5].
In the context of this thesis however, as a pre-processing step for the application of 
organ-wise registration and due to the limited available data a semi-automated tech-
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nique based on thresholding is used. Figure 3.5 shows the original CT data along with 
the overlaid segmented organs.
Surface renders obtained for the segmented 3D models of the organs at risk are also 
visualised using itksnap in Figure 3.6:
These surfaces of the segmented 3D models of the organs-at-risk and lung tum our are 
then further decomposed into point clouds as shown in Figure 3.8 for each phase of 
the breathing cycle, which are then used as an input for the organ-wise registration. 
Figure 3.7 displays the surface obtained from the segmented lesion from PO PI patient 
P I data. This will be further discussed in the next section.
3.4 Image Registration
The process of image registration is to basically determine the spatial transformation 
tha t will bring homologous points or regions within images or between physical space 
and images, being registered into correspondence [map into the same coordinate system] 
[42]. This can be considered as the mathematical form of the desired spatial transfor­
mation can be limited by physical principles. When registering images acquired from 
the same subject, often assumptions are made tha t the anatomical region considered 
can be treated as a rigid body, which leads to highly constrained spatial transformation 
model. However, physical processes such as respiratory-induced motion involved in the 
acquisition and reconstruction of medical images [20] can cause artifacts and lead to 
violations of rigid body model even if the anatomical region considered strictly ad­
heres to rigid body constraints [7]. The primary focus or the operational goal of image 
registration is to quantify the aforementioned involuntary motion such as respiratory- 
induced motion so tha t their influence on the data can be alleviated or even eliminated. 
Once the desired spatial transformation is derived, image resampling and interpolation 
models must be utilised to compensate for motion and create the registered image.
W ith the advances in medical imaging technologies 3-dimensional (3D) images are ac­
quired by different tomographic modalities such as computed tomography (CT), mag­
netic resonance imaging (MRI), single-photon emission computed tomography (SPECT)
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(a)
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(b)
Figure 3.5: Segmented and visualised from itksnap the (a) orignial CT data and (b) 
the segmented tumour and organs at risk from patient 1 of POPI data
3.4. Image Registration 47
(a) (b)
(c) (d)
Figure 3.6; Segmented and visualised using itksnap of the 3D models of the segmented 
organs’ surface renders from patient 1 of POPI data (a) lungs (b) liver (c) kidneys (d) 
spleen.
Chapter 3. Treatment Planning: Respiratory-induced Motion Extraction
Surface render o f  volum etric data  o f  the les io n  P O P I/P l
Left-Right (LR) (mm) 245
Anterior-Posterior (AP) (mm)
Figure 3.7; Illustration obtained through MATLAB, the surface render of the lesion 
th a t was previously segmented from the patient’s dynamic CT data.
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Figure 3.8: Illustration of the decomposed point cloud obtained from the surface of the 
segmented lesion displayed above, as a preprocessing step for the image registration.
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and positron emission tomography (PET). In each of these modalities a contiguous 
set of 2-dimensional (2D) image slices provides a 3D array of image intensity values. 
As explained in [79], within the current clinical settings such as diagnostic, planning, 
performing and evaluating surgical and radiotherapeutical procedures, the employed 
imaging techniques can be broadly categorised into 2 classes, namely, anatomical and 
functional. Anatomical modalities, i.e. depicting primarily morphology, include X-ray, 
CT (computed tomography), MRI (magnetic resonance imaging), US (ultrasound), por­
ta l images and video sequences obtained by various catheter scopes, e.g. by laparoscopy 
or laryngoscopy [79]. Functional modalities, i.e. depicting primarily information on the 
metabolism of the underlying anatomy, include (planar) scintigraphy, SPECT (single­
photon emission computed tomography), PET (positron emission tomography), which 
together make up the nuclear medicine imaging modalities and fMRI(functional Mag­
netic Resonance Imaging) [79]. Although, gross changes in the serial images can be 
detected by a visual comparison of the images at different time points, image registra­
tion enables the detection of the subtle changes. Once the serial images are registered, 
subtraction can be used for visualisation and quantification. Image registration is also 
an im portant tool used for correlating information obtained from different modalities.
Image Registration in the context of this thesis is used solely for the purpose of ex­
tracting the tumour motion from the scanned CT images obtained during the treatment 
planning stage. This is an im portant pre-processing step in the grand scheme to esti­
mate the motion and subsequently predict and carry out a better treatm ent plan for 
delivering correct dosages in radiotherapy. The tumour motion parameterization will 
determine in which axis respiratory-induced motion will occur (anterior-posterior (AP), 
left-right (LR) or superior-inferior (SI) directions) and how much respiratory-induced 
motion there will be during a typical scanning session. This will give better insight so 
as to how the tumour behaves during breathing and will help delineate better volume 
margins tha t will subsequently reduce the overall dosimetry and increase healthy tissue 
sparing.
Van den Elsen et al, 1993 [28], classifies the registration methods into nine differ­
ent categories, namely, dimensionality, nature of registration basis, nature of trans­
formation, domain of transformation, interaction, optimization procedure, modalities
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involved, subject and finally the object. Image dimensionality would refer to the image 
spaces involved. Typically in medical imaging applications would be 2-dimensional or 
3-dimensional image data sets. The registration basis would be the aspect of the 2 
views used to effect the registration. Meaning whether the registration is carried on
a set of points or surfaces or volumes, etc  The nature of transformation and the
domain of transformation are sometimes categorised together and named as geometric 
transformation as explained in [34], refers to the geometric mapping used to align the 
points in one coordinate system. The degree of freedom also known as the degree of 
interaction, refers to the control exerted by a human operator over the registration al­
gorithm. This sometimes may contain only the initialisation of parameters or in certain 
instances may involve adjustments throughout the registration process in response to 
visual assessment of the alignment or to the measures of intermediate registration suc­
cess [34]. Optimization procedure is where the function is maximised or minimised. In 
the ideal situation in this case, a closed-form solution will produce the global extremum. 
However, the common approach is to find the global extremum among many local ex­
tremums by means of an iterative search. Modalities would mean the method of image 
acquisition of the registered image data sets. The modalities could be both intramodal 
(monomodal) if they are of the same modality, such as, CT-CT or intermodal if they 
are of different modalities, such as, SPECT-CT or MR-PET. The subject is usually 
the source or the image data set tha t will be registered to, can be categorised into 3 
subcategories, namely, intrapatient, interpatient and atlas. Finally, the object would 
be the data set tha t will be registered to the source image data set. Typically, the
region of anatomy eg., head, liver, etc Among all these aforementioned categories
the most im portant of them all would be the geometric transformation which is also be 
known as the spatial transformation models. This will determine the outcome of the 
registration on the selected image data sets.
3 .4 .1  S p a tia l T ran sform ation  M o d e ls
Spatial transformation models also known as the geometrical transformations, are a 
salient condition tha t needs to be fulfilled in the registration process. These trans­
formation models will impose the mathematical constraints on the types of geometric
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distortions (parameters) that can be imposed during the process of registration [7]. 
The goal of the registration is to find the optimal for these parameters with respect 
to the registration criterion [132]. These can be divided into linear (rigid, affine) and 
non-linear transformation models (spline warps, truncated basis function expansions, 
Navier-Lamé equations or by a viscous fluid model [91]) and will be discussed further 
in the following sections. Linear transformation models range from rigid-body models 
tha t preserve internal angles and distances of the image data sets, to perspective mod­
els tha t distort all distances and angles while preserving co-linearity. A given linear 
transformation model can then be depicted as a 3-by-3 matrix for a 2D linear transfor­
mation and a 4-by-4 matrix for a 3D linear transformation. Any coordinate (x,y) can 
be assigned to a vector as follows,
X
(3.1)
The extra final element is viewed as a pragmatic placeholder to help solve the math­
ematics. These placeholders will ensure tha t transformation matrices can be inverted 
or multiplied to obtain the appropriate results. However, should the final element be a 
non-zero value other than unity then the entire vector will be rescaled by a scalar value 
and then interpreted as a homogeneous coordinate [7].
In the most rudimentary sense a transformation model can be defined as follows. If 
points from space X  (first view) is mapped onto points from space Y  (second view), 
then the transformation r  applied to a point in X  represented by the column vector x  
will produce a transformed point x \
x' — r(x)  (3.2)
Given a successful registration the point y  in space Y  corresponds to x,  the final
transformation x ’ will be equal or approximately equal to point y. Any resulting
errors tha t would describe the non-zero displacement, will be in the form
error =  r{x) — y (3.3)
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Defining the positive and negative ends of the cardinal axes requires an arbitrary choice 
between two different coordinate systems tha t are effectively 3-dimensional mirror im­
ages [7]. Therefore, it is im portant to note tha t throughout this chapter transforma­
tions tha t are describing mirror imaging (i.e, spatial inversions) are not discussed for 
the purpose of this thesis.
3 .4 .2  R ig id  T ran sform ation  M o d e l
This is the most constrained type of spatial transformation model. This model pre­
serves all internal angles and distances within the images. It is considered th a t the 
object behaves in the real world as a rigid-body model (such as bones which cannot 
be deformed) and is susceptible to global rotations and translations but internally im­
mutable. This model is well suited for rigid-body models such as bone structures th a t 
cannot be deformed under any circumstances. Rigid body models consists of two salient 
components namely, rotations and translations. In 3D, rigid-body model consists of 6 
independent parameters^, where 3 parameters describe the 3D translations along each 
of the primary coordinate axes tha t is then followed by the sequential application of the 
rotations around each of the primary coordinate axes. Therefore, if the transformation 
r  is rigid, then it can be expressed as follows;
x ’ =  R x  - f t  (3.4)
Typically, the translation component is a 3D vector t.
When considering medical images, these images are often acquired and processed in 3D, 
for example (CT, SPECT, MRI, e tc ... ). Consequently, as in the case of MRI imaging 
data [7], the possibility of differing distances along the x, y, z-axes in each voxel needs 
to be accounted for in real world. If ignored, these anisotropies in voxel size may lead to 
apparent violations of the rigid-body model [7]. Consequently, any implementation of 
a rigid-body model must explicitly correct for voxel sizes to remain immutable. One of
^AIso known as degrees of freedom (DOF). These are the number of parameters needed to describe 
the registration transformation.
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the main advantages of using rigid body model matrix formulation is tha t it eliminates 
the need to specify whether the rotations precede or follow the translations. This is 
due to the fact that rotations are conceptualized as taking place around the origin of 
the chosen coordinate system. Another advantage of this matrix formulation is that 
it allows the use of standard linear algebraic methods for transformation inversions or 
combinations. However, the downside to rigid transformation is that it is not always 
easy to verify that a particular transformation may necessarily describe a rigid-body 
model. Although, in 2D case by inspecting the transformation matrix symmetry this 
can easily be verified, in 3D however, this is not the case. A typical way to rectify 
is to use the singular value decomposition [7]. The decomposition will produce three 
matrices two of which are orthonormal^ and a identity matrix.
Rigid-body transformation is the basic implementation of the popular iterative closest 
point algorithm described by Besl and McKay [10], which will be described in detail 
further in the chapter.
3 .4 .3  A fR ne T ran sform ation  M o d el
Affine transformation consists of added features such as scaling and shearing for the 
rigid transformations. These transformations preserve the parallel lines while any 
straight line in one image will transform into a straight line in the other, allowing 
a combination of rigid-body motion, scaling, and skewing (or shearing) about any of 
the cardinal axes [42]. Affine transformations in 3D, can have 7 DOF, 9 DOF or 12 
DOF for transformation and will depend on the type of registration that needs to be 
performed.
A global rescaling transformation has 7 DOF, where the seventh parameter specifies 
the magnification factor that is applied globally to rigid-body transformation matrix 
[7]. Instead of uniform rescaling along the three cardinal axes, it is also possible to 
rescale anisotropically^. However, since the order in which rotations and rescaling are 
performed matters due to anisotropy, in the case of 9 DOF affine transformations, this
^This means that they can be viewed as describing the rigid-body rotations
'^anisotropy means that the distances are directionally dependent as opposed to isotropy where 
identical properties are exhibited in all different directions.
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model does not compromise the closed form sets under matrix inversion and multipli­
cations [7]. Affine transformation models can be mathematically shown as follows:
Global scaling (7 DOF) in a more general sense can be as follows:
x ’ =  S R x  -f- t
where, S  is the scaling factor, R  is the rotation m atrix and t is the translation vector. 
The scaling factor S is a diagonal matrix whose elements represent scale factors along 
the three cardinal axes. This can also be represented as follows, S =  diag(sa;; Sy, Sz), 
unless the scaling is isotropic whereas Sx = Sy = Sz = s. In this case the transformation 
would be a global rescaling transformation with 7 DOF.
A general affine model in 3D however, could have upto 12 DOF. A salient geometric 
constraint of this model is that, lines tha t were parallel before transformation will 
remain parallel even after the transformation.
3.5 Iterative Closest Point M ethod
A widely used iteratively matching technique introduced by Besl and McKay [10], was 
used for organ-wise registration and parameterisation of the lung tumour. Iterative 
closest point (IGF) is a general purpose representation-independent method for the 
accurate and computationally efficient registration of 3D shapes including free-form 
curves and surfaces [10]. This algorithm involves the computation of minimising the 
distance from the model point set M  to the target data point set D iteratively until 
convergence. One of the first steps is to align the center of masses of the source and 
target point sets to each other. This is performed in order to allow the point sets 
to have a common origin when matching of the surface points is taking place. The 
transformation parameters, translations t, rotations R , scaling S and shearing Sh  are 
subsequently applied to the source point set moving it closer to the target point set. The 
combination of assigning closest points, transformations and surface point alignment 
performed iteratively converges to the best alignment of the source and target surface
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point sets. Convergence is detected when the fitting error ÔE falls below a pre-set 
threshold r .  The surface point set fitting with the ICP approach is described as follows;
A lgorithm  1: Iterative Closest Point (ICP) Algorithm 
w hile ÔE <  r  do
Set initial parameters
Compute the closest points between Mg and Pg 
Compute the rigid-body transformation T
Apply the transformation to the source point set Ms{k -f 1) =  TMg(&) 
end w hile
As previously discussed, to perform the surfaces obtained from the segmented 3D mod­
els of the lung tumour and OAR, were further decomposed into point clouds for each 
phase of the breathing cycle and consecutive phases were used to perform the organ-wise 
registration. Although, the original authors of this method [10] consider only 6 DOF, 
for this research a general affine model (12 DOF) using ICP has been used. ICP is used 
to perform the organ-wise registration iteratively with the previously segmented organs 
and quantify the organ and tumour motion. Thereby, quantifying and extracting the 
respiratory motion from the 4D CT data sets.
When performing ICP registration a typical observation is tha t when the fitting error 
falls below the pre-set threshold, the rms error will begin to converge towards a mini­
mum fitting error. Figure 3.10 allows to observe the fitting error has in fact converged 
when fallen below the pre-set threshold. The observation of the convergence is an im­
portant step to determine that the registration algorithm has in fact calculated the 
minimum error for the given data sets. Thus, saving the computational cost of per­
forming the algorithm. The fitting error curve obtained as an exemplar, in Figure 3.10 
illustrates tha t from the second iteration onwards the fitting error begins to converge to 
its minimum rms error that is approximately 0.79 mm. The convergence occurs fast in 
this case, due to the small number of data points in the lesion that was registered and 
also due to the displacement of the lesion motion being small between the two phases. 
Therefore, it is important to note tha t bigger data sets and larger displacements be­
tween the two data sets could yield in higher computational cost leading to longer time 
to  converge to the minimum error.
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Figure 3.9: Illustration of the registered point clouds of consecutive frames of the 
lesion POPI data set-Patient 1, where the red and blue point sets depict two different 
phases of the breathing cycle of the lesion.
3.6 Extraction of Respiratory M otion from Simulated D ata
The current version of XCAT 2 phantom developed by [100] is used to obtain 128x128x128 
dimensional 4DCT image data sets over a period of 10 phases (frames) representing one 
breathing cycle starting with the maximum exhale. In this case, the 4DCT volumes 
assume normal breathing. The aforementioned phantom preference was chosen as male 
and parameters shown in Table 3.2 were also used to simulate the data. These 4DCT 
image data sets were segmented by changing the parameter file values for each organ 
individually to obtain the segmented organ volume.
Figure 3.11 illustrates the diaphragm motion over a period of one breathing cycle with 
10 phases as mentioned in Table 3.2. Motion begins at 0, as the 4D-XCAT phantom ’s 
breathing cycle was set to begin at maximum exhale which is denoted by the value.
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Figure 3.10: Illustration of the convergence of ICP registration for a lesion registered 
to the consecutive phase of the breathing cycle. The fitting error was observed over 15 
iterations.
R espiratory M otion Param eter File
dimensions 128x128x128
no. of frames 10
pixel width 0.3125cm
respiratory period 5s
max. SI motion 2cm
max. AP motion 0.5cm
starting phase max. exhale
Table 3.2: Parameters used for generating 4DCT image data sets from 4D XCAT 
phantom
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The XCAT phantom has a breathing range from 0-0.4 where the 0.4 typically denotes 
the maximum inhale phase. As expected the motion in the last frame does not reach 
all the way upto zero, due to the fact that in a breathing cycle starting point does not 
typically align with the end point (As previously explained in Chapter 2, this is known 
as hysteresis).
D iaph ragm  (SI) m otion  fro m  4D-XCÂT
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Figure 3.11: Illustration of the diaphragm motion in the SI direction over a period of 
10 phases (one breathing cycle).
Figure 3.12 illustrates the mean error obtained for all organs over one breathing cycle. 
This clearly illustrates the error is minimum when it is closest to the reference phase. 
The close proximity to the reference phase means calculation of the closest points would 
result in smaller errors. Another important observation is that although, rigid body 
models such as bones inherently do not attain  higher registration errors, ribs in this case 
show relatively high error. This is due to the involuntary respiratory-induced motion 
that causes the ribs to deform. Hence, the disparity in the error values for the ribs. 
Lungs attain the highest error value since, lungs are the most affected and deformed 
mostly by the respiratory-induced motion. Thus, higher deformation in organs causes 
to obtain the higher disparity in error. Organs tha t are not affected due to respiratory- 
induced motion retains a reasonably lower error margin.
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Figure 3.12: Illustration of the obtained ICP error values of all segmented organs over 
one breathing cycle.
Registering individual organs or tumour to consecutive breathing phases in one breath­
ing cycle allows to observe the actual motion of the tumour or the individual OAR^ 
during breathing. As the registration concludes, the final transformation parameters 
are generated allowing to localise the tumour or OAR. These parameters can infer the 
tum our or OAR motion occurring in each dimension (AP, LR, SI). Thus, extracting 
the respiratory-induced tumour and/or OAR motion.
3.7 Validation of the Registration Algorithms
Validating of the registration accuracy is generally not a straight forward task. However, 
previous literature [7, 34, 130] have categorised validating methods used for registration 
as follows:
• Validation by visual inspection
• Validation of point fiducial based registration and cross-validation using external 
fiducial gold standards
• Sensitivity to starting parameters and statistical modelling
^organs-at-risk
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• Simulations
• Validation of inter-subject warping
However, for the purpose of this research validation of the research will be carried out 
by means of visual inspection and also by comparison of clinical data  with simulated 
data.
3.8 Summary
A critical step in radiotherapy procedures is to delineate the target volume margins, 
specifically the PTV margin where the actual dose would be delivered. Patients’ in­
voluntary breathing during the scanning period (treatment planning) could distort the 
scanned images leading to erroneous dosimetry. Therefore, it is critical tha t the lung 
tumour or any other OAR be localised initially. Tumour localisation can be classified 
to direct methods, indirect and hybrid methods [85]. Although, deformational changes 
occurs in intra-fractions and inter-fractions, one of the major limitations with current 
clinical systems is tha t they can track only translational changes of a single point 
(the center of the tumour). Real-time volumetric imaging techniques such as, 4D CT 
can therefore, capture translational as well as deformational changes. To extract and 
quantify the aforementioned respiratory-induced motion popular iterative registration 
method (ICP) by Besl and McKay [10] is used. These preliminary results illustrate th a t 
the organs tha t aid or that are positioned closest in anatomical region to the general 
breathing mechanics, are affected heavily by the respiratory-induced motion. Espe­
cially, since the tumour is also located directly in the lungs, elevated levels of motion 
can be observed over a period of one breathing cycle. However, it has been observed 
tha t this motion does not exceed ±3mm.
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Chapter 4
Respirât or y-induced M otion  
Correlation M odel
W ith the ever-changing state-of-the-art medical technologies, it has become increasingly 
popular method to irradiate tumours while patients breathe freely. Adler et al [3], 
developed Cyberknife which is the leading technology in clinical practice of treatm ent 
delivery for respiratory-induced tumours without the aid of gating, respiratory coaching 
or fixation. However, in many cases, it is necessary to use an external surrogate signal 
to infer the tum our’s changing position. Typically, this is performed by correlating 
external markers and the landmarks of the tum our obtained during the imaging session 
in the treatm ent planning stage [57, 99]. Hoisak et al [46], demonstrated the feasibility 
of using such external-internal correlation model between the tum our motion and the 
external markers, to guide the robotic arm carrying the linear accelerator to reduce or 
eliminate the effects of respiratory motion. However, the external chest motion and 
internal tumour motion may change and therefore, this correlation model needs to be 
updated periodically. Thus, for many new technologies such as. Cyberknife, building a 
correlation model between the tumour and the surrogate (internal or external) should 
be established before each treatm ent fraction and updated during the treatm ent session 
at a frequency depending on the region of the tum our and the individual patient [22, 99]. 
To allow treatm ent to  be non-invasive and avoid overdosing patients, previous literature 
[15, 23] also points out the importance of correlation models tha t use external surrogate
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markers to observe the internal tumour motion.
P roblem  statem ent: B uilding a respiratory-induced m otion correlation m odel 
for m otion betw een lung tum our and internal or external surrogate.
The previous chapter detailed the quantification and extraction of the respiratory mo­
tion from a patient. Respiratory motion models are used in a variety of medical ap­
plications such as dose calculations in external-beam radiotherapy (EBRT), developing 
respiratory motion phantom [100], internal organ and external surface correlation [33] 
are to name a few. For the purpose of this research, it is assumed that the correlation 
between the tumour and the indirect surrogates is stable over the entire treatment 
course.
This chapter analyses the respiratory-induced motion that was extracted as previously 
explained in Chapter 3, with the aid of principal components analysis (PCA). The 
next section then details the use of canonical correlation analysis (CCA) to obtain 
the respiratory-induced correlation model. The correlation model was initially built 
for indirect tumour localising methods. Therefore, the aforementioned methods will 
analyse and build correlation models for.
• motion between the lung tumour and the external surface markers
• motion between the lung tumour and the internal surrogate organs (lung, liver)
In order to obtain a better understanding of how the tumour motion behaves with 
different viewpoints, the internal surrogate lung motion was analysed from different 
viewpoints with respect to the lung tumour motion. Since, the acquired CT image 
data sets all had the tumour growing on the right lung, different viewpoints of the lungs 
analysed the right lung, both lungs and from the bottom of the right lung viewpoints 
motion with respect to the tumour motion. Since, each patient has a different body 
structure the analysis of different viewpoints would aid in building a global correlation 
model tha t is adapted to individual patient specifications for treatm ent stages.
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4.1 Respiratory-induced M otion Reduction in Dim ension- 
ality
Registering the consecutive phases of the segmented organs give output parameters for 
superior-inferior (SI), anterior-posterior (AP) and left-right (LR) dimensions. Espe­
cially, if a general affine transformation was used it would give 12 DOF as opposed 
to a rigid-body model giving only 6 DOF along each of the cardinal axes. Since, the 
obtained image data are all 4D-CT th a t is in three dimensions it may pose difficulties in 
describing each individual parameter to predict the tumour motion. This is due to the 
fact tha t each individual registration parameter would have 3-dimensions to describe. 
Therefore, a reduction in dimensionality would certainly increase the probability of 
attaining a more accurate next phase of the respiratory cycle thereby determining the 
tumour motion. Thus, eliminating the need to include all of the parameters into the 
motion model with minimal marginal errors. Dimensionality reduction is often used to 
deal with redundancies and noise containing in real-life image data sets. When using 
low dimensional representations noise can be suppressed and redundancies removed 
[11]. This is an im portant preprocessing step towards other algorithms, clustering, 
etc... Although, many methods are used for dimensionality reduction they all rely on 
the inner products and on eigenproblems. The difference between such methods is the 
cost function they optimize. One of the widely used methods for dimensionality reduc­
tion is the principal component analysis (PCA) [55]. In order to compactly describe 
the respiratory-induced motion tha t would describe the optimal direction of motion, 
PCA computation was performed on the extracted motion described in the previous 
chapter.
4.2 Principal Component Analysis
Principal component analysis (PCA) also known as Karhunen-Loeve (KL) transforma­
tion identifies a linear transformation of the coordinate system. This is as such th a t the 
cardinal axes of the new coordinate system coincide with the direction of the largest 
spreads of the points distribution. However, in the new set of axes data are uncorre­
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lated. These transformations are performed as such tha t the greatest variance by any 
projection would lie on the first coordinate or the first principal component. The second 
greatest variance or the second principal component on the second coordinate system
and so forth Jolliffe [55] explains, it is assumed that the directions of high variance
will also contain more information than the directions of low variance since, noise can 
be assumed to be uniformly spread. Thus, the directions of higher variance will have 
a higher signal-to-noise ratio (SNR). It is also im portant to note that typically, PCA 
retains the dimensionality. Therefore, the same number of principal components can 
be observed. Figure 4.1 illustrates the motion data spread over the 3 dimensions (AP, 
LR, SI directions).
F ig u re  4.1: Illustration of the use of PCA for dimensionality reduction by [125]. The 
maximum spread of the cluster represents the overall motion along the first principal 
component (the big red axis) and the small red axis represents the second principal 
component and its spread respectively.
Prior to analysing the aforementioned respiratory-induced motion with PCA, the D- 
dimensional space vectors of the lung tumour, organs-at-risk position or even the an­
terior external surface markers with a column vector is defined as follows:
(4.1)
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where, n E % is a time index describing the respiratory phase, Xn,i,  Yny, Zn,i are all 
registration parameters tha t describe the transformation used, 1 through m  describes 
the dimensions at phase n.
The respiratory motion sequence or the number of phases in a breathing cycle for each 
organ and each patient is described in the m atrix M.
M = [F i,F 2 ,T b , (4.2)
In the above matrix M the mean of each row is subtracted from all the values in the 
same row to produce an average position of the variation of tha t data  set Fq. This is 
equivalent to translating to the center of the coordinate system. This remaining value 
produce an adjusted data set whose mean is zero. Thus, by finding the eigenvectors 
and eigenvalues of the covariance m atrix C, the principal components for this adjusted 
data can be given as follows:
0 = -  -  Po){Fi -  F o f  (4.3)
The resulting K  pairs of eigenvectors (ei,e2 ,...efc) and eigenvalues A of the aforemen­
tioned covariance matrix C can be used to aptly describe the extracted respiratory- 
induced motion. Each eigenvalue is proportional to the variance^ and is arranged in 
decreasing order.
In this research, PCA is used specifically to reduce dimensionality and define the direc­
tionality of the respiratory-induced motion of the tum our and of the lungs and other 
OAR, as it shows the highest variance in any given number of dimensions and makes 
other information redundant in other dimensions. It also helps make an informed deci­
sion of not only the directionality but also the magnitude of the motion vector as well. 
This is an im portant step as the extracted respiratory-induced motion produce four 
parameters (translation, rotation, scaling and shearing) for each of the cardinal axes in 
3D.
i^n other words the sum of squared distances of the points from their multi-dimensional mean given 
a euclidean space.
68 Chapter 4. Respiratory-induced Motion Correlation Model
4.3 Canonical Correlation Analysis
Canonical correlation analysis (CCA) is a method tha t was proposed by Hotelling 
[48] which is used to maximise the linear relationship between two multi-dimensional 
variables. In the most simplest case, this method consists of paired data. Conversely, 
CCA can be used to correlate higher orders of data as well. One of the salient features 
of using CCA is tha t it does not depend on the affine transformations of the variables. 
This is a model tha t is used to detail the correlation between a surrogate organ or 
external markers and the lung tumour motion.
Hardoon et al [44], explains tha t given two vectors tha t needs to be correlated (in this 
case the lung tumour motion vector and the internal surrogate organ or the external 
marker’s motion vector), in the form of (x, y) and given a sample of instances in the 
form of Î7 = (x i ,X 2 , . . . ,  Xn) and V  = (yi ,y 2 , . . . ,  y-n) where, n is the number of overall 
data parameters and U and V are motion vectors respectively. A new coordinate for x  
by choosing a direction where the projection can be defined as follows:
X-)- (wa;,x) (4.4)
(4.5)
Thus, we obtain the following sample of new coordinate values
U x , w x  ~  ((^^z) x i ) , . . . ,  (wg;, x^)) (4.6)
=  ((Wi/,yi),. . . ,  (Wy,y^)) (4.7)
In order to maximise the correlation between and Wy in CCA, the function that 
needs maximising is.
p =  max corHjJ^Wx^VyWy) (4.8)
=  max (4.9)
W^,Wj, ||LAWa;||||T^Wy||
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Let, the empirical expectation of a function f(x,y) denote as follows:
Therefore, the correlation expression can be rewritten as;
(4.10)
max ^  n K x y ' w y ]
/Ê [ (« ;„ x )2 ]Ê [ (« , , ,æ )2 ]  ^È[w',xx'w^]È[vj'yVy’wy]
(4.11)
p =  max ------
. !w'^'E[x, x ']w x w 'Æ [yÿ]w y
The correlation matrix will now be in the form of:
C{x, y) = Ê
(4.12)
Cxx Cxy = c. (4.13)
Cyx F'yy
This total covariance matrix C is a block m atrix and although the covariance m atrix 
shown above is only for a zero-mean case, the function p can be rewritten as follows;
p = max
W x , W y  y / w ' ^ C x x ^ X ^ y C y y W y
(4.14)
Thus, the maximum canonical correlation is the maximum of p with respect to Wæ and 
Wy. The solution in 4.14, p is not affected by rescaling w-c and Wy either together or 
independently since, multiplication by a scalar does not change the value of p. Since, 
the choice of rescaling is arbitrary, the CCA optimisation problem in 4.14 is equivalent 
to maximizing the numerator subject to the following:
''^xF'Xx''^X — 1
■^yCyyWy = 1
(4.15)
(4.16)
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Therefore, the corresponding Lagrangian is.
T(A, W a;, W y )  =  W^Cæi/Wy -  ^(w^CarZWa; -  1) -  ^ ( W y C y y W y  -  1) (4.17)
Lagrange derivative with respect to w^ and Wy ,
Cxy^y ^X^xx^X  — 0 (4.18)dw
— Cyx'^x ^yFyy^y  — 0 (4.19)aWy
by solving the above 4.18 and 4.19 gives,
0 =  AyWyC?/^Wy -  Aa;W^ Ca;a;Wa, (4.20)
which implies the following Ay - A^ , =  0 , let, A =  A^, =  Ay. W ith the assumption that
Cyy gives,
w , =  (4.21)
Therefore, substituting 4.18 the following is obtained.
CxyCyylCyx^W^x — A Cxx^x  (4.22)
The obtained formula is in the generalised eigenproblem of the form Ax =XBx. There­
fore, by solving the for the generalised eigenvectors of equation 4.22 to obtain the 
w^ sequence and subsequently using equation 4.21 to obtain the Wy, the coordinate 
system tha t optimizes the correlation between the corresponding coordinates can be 
found.
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4.4 Evaluation of the Correlation of Respiratory-induced  
M otion M odels
A set of 4D CT images obtained by the Royal Surrey County hospital (RSCH), was used 
to extract the respiratory motion tha t was previously discussed in chapter 3. These 
image data sets are with a 512x512x112 dimensionality and has a voxel spacing of 2.384 
mm^  and has a breathing cycle of 10 respiratory phases. This data  first extracts the 
respiratory-induced motion of the lung tumour and the internal-external surrogates 
(lung, liver, external markers). Subsequently, PCA was used to reduce dimensionality 
and to find the maximum variance in the extracted respiratory-induced motion. The 
output will consist of a set of principal components tha t is proportional to the number 
of input parameters and will clearly define the dimension with the maximum variance. 
Finally, to build the respiratory-induced motion correlation model, the aforementioned 
CCA was used to correlate the motion between the tumour and internal surrogate 
organs (lungs, liver) and also to correlate motion between the tum our and the external 
markers. In order to illustrate the velocity and directionality of the above mentioned 
motion, additional quiver plots are also analysed. These are plots illustrates the path 
of the motion projectile as a function of time.
z{t) = v z t +  —  (4.23)
4 .4 .1  A n a ly s is  o n  th e  L ung T u m ou r M o tio n
First and foremost, PCA was performed on the lesion after its motion had been quan­
tified by ICP registration method. The input parameters for the PCA m atrix were 
in fact the transformation parameters tha t were generated through the process of ex­
traction of the respiratory-induced motion. This will output registration parameters 
(translations, rotations^, etc...) in each dimension (LR (x), AP (y), SI (z)).
From the above Figure 4.2 it can be seen tha t in this case, the tum our translates
^parameters, theta, psi and phi are all angles of rotations in the direction of LR, AP and SI
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PCA (mat cmd) on VENI LESION
tx ty tz theta psi phi
principal components
F ig u re  4.2: Illustrations of the principal components obtained when PCA was per­
formed on the lung tumour after quantification of its motion.
along the lateral (LR) direction^ more than any other direction. Although, minor 
rotational changes occur along each of the cardinal axes, more translational changes 
can be observed along the lateral direction. This is not general overview of how the 
lung tumours behave but patient specific.
4 .4 .2  A n a ly s is  o f  th e  M o tio n  B e tw e e n  E x tern a l S u rface M arkers and  
L u n g T um ours
As previously explained in Chapter 3, using indirect methods for tumour localisation 
can at times be beneficial since, they infer the spatial transformation of the tumour 
from some surrogates tha t can easily be located. First, the top most external surface 
marker on the patient was chosen as an external surrogate to observe the motion path. 
After extracting the marker positions for the given number of breathing phases, PCA 
was performed to obtain the dimension of maximum variance on the external surface 
marker positions. It can be seen in Figure 4.3, that a maximum variance occurs in the
^the X direction denoted in the plot depicts LR motion, y direction depicts AP motion and z direction 
depicts the SI motion
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lateral direction or the x-dimension. Although, the norm would be to expect the top 
most marker to move in the AP direction, the observations and calculation of PCA 
determines that the top most external surface marker moves in the lateral direction. 
This is due to the breathing mechanics explained in Chapter 2. It is im portant to note 
the directionality as it could lend the radiation oncologist to place the marker in a more 
adaptable manner to capture the AP motion.
& 
y  50
PCA on external thoracic marker positions-VENI
x(LR) y(AP) 
principal components
z(SI)
Figure 4.3: PCA on the external markers of VENI data illustrates the highest variance 
along the lateral direction.
The signal variation of the top most external surface marker detailing the respiratory- 
induced motion across all three directions (LR, AP and SI) is illustrated in Figure 4.4. 
This validates the motion obtained by the PCA plot shown above.
Figure 4.5 illustrates the correlation between the tumour and the top most exter­
nal thoracic marker. The correlation coefficient begins high in the SI direction and 
gradually fades as the breathing reaches its maximum inhale position. However, the 
correlation coefficient remains almost a constant in the AP and lateral (LR) directions. 
This concurs with the breathing mechanics as explained in Chapter 2. However, it is 
im portant to note the following correlation between the tumour motion and the tho­
racic/abdominal surface motion depends on the individual patients and motion changes
74 Chapter 4. Respiratory-induced Motion Correlation Model
signal Variation on External Thoracic Marker Motion - VENI
I
frame
F ig u re  4.4: Signal variation on the top most external surface marker when performing 
the PCA.
can also occur between fractions. This is due to patients having different tissue thick­
ness in the thoracic/ abdominal region as well as, external markers are not always placed 
on the same exact location each time by the radiation oncologists.
Figure 4.6 illustrates the velocity vectors of the motion at (LR, AP, SI) directions. This 
helps determine the velocity at which the motion is occurring (rate of change between 
frames) and not just the direction of motion. These help understand the patient’s 
breathing pace as well as determining the directionality of the motion.
4 .4 .3  A n a ly s is  o f  th e  In tern a l S u rrogate  O rgans and  th e  L ung T um our
Since, in this research the focus is on lung tumours the chosen internal surrogate organs 
were the lung and the liver. The liver in this case was also used as an internal surrogate 
solely because the 4DCT data sets obtained presented the lung tumours all on the right 
lung. The lung tumour was observed in different viewpoints such as the motion observed 
from the bottom of the lung, when both lungs were chosen as surrogate as opposed to 
just observing the lung where the tumour is already located at. The following figures 
illustrates the PCA performed and subsequently the CCA that was performed to find
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CCA on lesion and top m ost external marker motion - VENI
il
Figure 4.5: Plot illustrating the correlation of the external marker (s) motion with 
respect to the lung tumour motion in eigenspace.
Velocity plot of canonical correlations between lesion and external thoracic marker-VENI
’ |  !  !  !  !  !  !  I
dimensional velocity (mm per sec.)
Figure 4.6: Velocity plot illustrating the directionality of motion with their respective 
velocities.
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the best correlation between the lung tumour motion and each of the internal surrogate 
organs.
A nalysis o f R espiratory-induced M otion B etw een  Lung and Lung Tumour
Since, the lung tumour analysed in most patients predominantly rests on the right lung, 
analysis of the motion between the tumour and the right lung, bottom of the right lung 
and both lungs were carried out. This was to observe the tumour motion from different 
viewpoints and observe any variation in respiratory-induced tumour motion from each 
viewpoint.
Figure 4.7 illustrates when PCA was performed on the entire right lung, major varia­
tions occur in the translational parameter in the LR direction and is illustrating quite a 
variation as compared to the rest of the registration parameters which are almost made 
redundant. Figure 4.8 illustrates the signal variation for all the registration parameters 
tha t were used as input to the PCA. Signal variations occur along the SI direction as 
well as the rotations occurring along the AP direction.
9  50
PCA on the entire right lung -VEN I
k  ty tz theta psi phi
principal components
Figure 4.7: Illustration of the PCA performance when considering only the entire right 
lung as the internal surrogate.
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Signal variation on Entire Right Lung - VENI
I
I
I
Figure 4.8: Illustration of the signal variation observed when considering only the 
entire right lung as the internal surrogate.
Figure 4.9 illustrates the correlation coefficient obtained between the lung tum our and 
the entire right lung in eigenspace. It describes each registration parameter tha t was 
matched with its corresponding direction (LR, AP, SI). The correlation remains high 
with exhalation while the correlation coefficient remains a minimum at maximum in­
hale.
Figure 4.10 illustrates the velocity change between each frame and each registration 
parameter (tx, ty, tz, 6*, ip, (jf) in each direction (LR, AP, SI).
Figure 4.11 illustrates the PCA performance on both lungs, and is almost similar to tha t 
obtained when PCA was used only on the entire right lung as illustrated in Figure 4.7 
with a slightly higher variation illustrating in Figure 4.11. However, when observing 
the signal variation for both lungs as illustrated in Figure 4.12, a considerable variation 
occurs in the rotational parameter in the AP direction. This occurrence can be ex­
plained with the mechanics of breathing and as the lungs expand, it also rotates along 
the AP axis.
Figure 4.13 illustrates the correlation coefficient between the lung tum our and both the
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CCA between lesion and rlgtit lung
Figure 4.9: Illustrates the correlation coefficient of the registered parameters between 
the lesion and the entire right lung in eigenspace.
Velocity plot of canonical correlations between lesion and Entire Right lung-VENI
param velocity (mnVs)
Figure 4.10: Illustration of the velocity change observed when considering the entire
right lung.
4.4. Evaluation o f the Correlation o f Respiratory-induced Motion Models 79
PCA on BOTH LUNGS -VENI100
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‘ ' ■
tx ty tz theta psi phi
principal components (reg param)
Figure 4.11: PCA performed when considering both lungs as the internal surrogate.
Signal variation on BOTH LUNGS - VENI
 1 1------------1—
-psi
frame
Figure 4.12: Signal variation observed when considering both lungs as the internal
surrogate.
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lungs. As compared to Figure 4.9 where, it illustrates the correlation of the entire right 
lung, Figure 4.13 illustrates a more constant correlation coefficient across all frames. 
This is due to the different viewpoint that the correlation variation occurs. When 
considering both lungs to measure the correlation of the motion between the lesion and 
the lungs, it may slightly obscure the degree of correlation.
CCA between lesion and both lungs
BJ -0.5
blungs,,) 
H H  p (les^ , b l u n g y  
F V ~ 1  pOBSfe. b l u n g y  
I I pOsSf
P(l«s». blungs^ 
p (les ., b lu n g s j
frame
F ig u re  4.13: Illustrates the correlation coefficient of the registered parameters between 
the lesion and both lungs in eigenspace.
Figure 4.14 illustrates more spread in the velocity changes as opposed to Figure 4.10, 
where a more detailed version of the motion is described.
Figure 4.15 illustrates the variations from the viewpoint of the bottom of the lung. 
This too is although very similar to the previously analysed lung motion, illustrates 
the translational variation along the LR direction. However, the signal variation illus­
trated  in Figure 4.16, shows the rotational variation in the AP direction. As explained 
previously this variation is due to the breathing mechanics of the lungs as it expands 
it rotates in the AP direction.
When considering from the bottom of the lung viewpoint, the correlation coefficient as 
illustrated in Figure 4.17 shows higher correlation coefficients across all frames. This
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Velocity plot of canonical correlations between lesion and BOTH lungs-VENI
g"
param velocity (mm/*)
-pii
F ig u re  4.14: Illustration of the velocity change observed when considering both lungs.
PCA on bottom of right lung -VEN I
fc< ty tz theta psi phi
principal components
F ig u re  4.15: PCA performed from the viewpoint of the bottom of the right lung as 
the internal surrogate.
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Signal Variation on bottom of right lung -VENI
I
-p s i
frame
Figure 4.16: Signal variation observed when considering bottom of the right lung as a 
viewpoint and as the internal surrogate.
is due to the close proximity of the lung tumour and the viewpoint. This gives a much 
better understanding of how the respiratory-induced motion affects the lung tumour.
The velocity plot illustrated in Figure 4.18 shows a more condensed velocity change 
across the respiratory frames. This again is due to the close proximity of the lung 
tum our and its observed viewpoint that describes in greater detail motion variations 
as opposed to the previous velocity plots.
A nalysis o f R espiratory-induced M otion B etw een  Liver and Lung Tumour
The following PCA was performed when liver was considered as an internal surrogate 
organ for tum our motion correlation. Liver on the other hand, as explained in Chapter 
2 illustrates considerable translational variation along the LR and AP directions. As 
the breathing occurs the diaphragm is pushed in the SI direction, causing the liver to 
move a small variation along the SI (tz) direction. It also causes the liver to compress 
and expand along the LR and AP directions which can be seen in Figure 4.19.
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F ig u re  4.17: Illustrates the correlation coefficient of the registered parameters between 
the lesion and the bottom of right lung in eigenspace.
Velocity plot of canonical correlations between lesion and bottom of right lung-VENI
param velocity (mm/a)
Figure 4.18: Illustration of the velocity change observed when considering the bottom
of the right lung.
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PCA on Liver Motion -  VENI
■ '  *
tx ty tz theta psi phi
principal components (reg param)
F ig u re  4.19: PCA performed when considering the liver as the internal surrogate.
Figure 4.20 illustrates the signal variations observed when performing the PCA on liver. 
It confirms the rotational variation along the LR and AP directions.
Figure 4.21 illustrates the relatively small correlation coefficients as compared to the 
correlation coefficients observed between lung tumour and different viewpoints of the 
lungs. Although, the variation of correlation in some instances is as high as ±2.5. This 
is due to the breathing mechanics that allow the liver to be in close proximity to the 
lung tumour during a breathing cycle. Hence, the higher correlation in such instances 
are observed.
Figure 4.22 illustrates more spread towards the positive axis of the graph. This depicts 
tha t the motion in the liver with respect to the respiratory-induced motion mainly 
moves in the same direction as the tumour.
The above graphs plotted shows the highest variance observed in tumour motion which 
indicates the probability of the tumour motion. It has been observed from the above 
results tha t when translations occur during the extraction of tumour motion along 
lateral direction a higher variance occurs. However, when velocity plots were studied it 
shows tha t the maximum correlation is in the rotating parameter cj) in the AP direction.
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Signal variation In liver - VENI
F ig u re  4.20; Signal variation observed when considering the liver as the internal sur­
rogate.
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F ig u re  4.21: CCA when considering the liver as the surrogate.
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Velocity plot of correlations between lesion and liver-VENI
param velocity (mm/s)
—  psi
F ig u re  4.22: Velocity change observed when considering the liver as the internal sur­
rogate.
These analytical plots gives information so as to how the tumour really behaves when 
patient breathes.
4.5 Summary
This chapter aims to build a respiratory-induced motion correlation model between the 
lung tum our and the external and internal surrogates. As a preliminary step the cor­
relation model was built between the lung tumour motion and the external surrogate 
motion. Subsequently, for the purpose of this research, correlation model was built be­
tween the lung tumour motion and the internal surrogate organs (in this case the lungs 
(from different viewpoints) and the liver respectively). The preliminary results show 
that, although, the external surface markers and tumour motion can easily be corre­
lated as it is a non-invasive procedure, it depends heavily on the patient’s anatomical 
structure and breathing pattern. As the location of the external surface markers may 
not always be placed accurately in exactly the same position in each treatm ent session.
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Thus, the suboptimal doses will be given to patients. Conversely, when using an inter­
nal surrogate although difficult it will give a better estimate of the breathing pattern 
and tumour motion during a breathing cycle.
In essence, the study helps better understand the breathing patterns for each patient 
and it also indicates tha t the respiratory motion parameters fluctuate in a partially 
correlated manner. In retrospect, the aim is to control the PTV margin and dose control 
by building a correlation model tha t will facilitate a description of the respiratory 
motion signal fluctuations compactly.
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Chapter 5
Im plem entation of the  
Respiratory-induced M otion  
Correlation M odel
The core objective of the treatm ent planning in EBRT, is to locate the tum our and 
find treatm ent parameters tha t will effectively maximize the treatm ent in the targeted 
region whilst reducing damage to normal tissue surrounding the targeted tum our in 
a non-invasive manner. However, patient’s involuntary breathing could be undesir­
able for radiotherapy treatm ent procedures, as such motion could lead to erroneous 
dosimetries. Thus, leading to over-dosing causing damage to surrounding healthy tis­
sues or under-dosing the targeted tumour during treatm ent delivery stage. Many have 
suggested previously the use of external surrogate markers to  account for the aforemen­
tioned respiratory motion [8, 99]. Correlating internal motion with a surrogate which 
is external or internal, as mentioned in the previous chapter and in previous literature 
[15, 23], could potentially facilitate a more tum our target-oriented patient’s treatm ent 
plan. Therefore, the goal is to build a motion correlation model th a t can adapt au­
tomatically to any patient. A first step is to check the feasibility of the proposed 
respiratory-induced motion correlation model.
Problem  Statem ent; Feasibility m atch o f th e  clinical im age data se ts  w ith
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P atient D im ensions Voxel size 
(mm^)
Lesion size 
(mm^)
PI 512x512x141 1.907 8923
P2 512x512x169 1.907 1946
P3 512x512x187 1.223 1553
P4 512x512x181 2.747 791
P5 512x512x161 2.747 5540
T ab le  5.1: The patient parameters for 5 patients each with 10 phases of breathing (or 
one breathing cycle).
th e  p ro p o sed  re sp ira to ry - in d u c e d  m o tio n  co rre la tio n  m odel.
This chapter will review the implementation of the respiratory-induced motion corre­
lation model tha t was described in detail in the previous chapter 4, on clinical data 
to determine the correct margins and doses for patient treatment. For the purposes 
of measuring the motion model’s behaviour with clinical data, 4DCT image data sets 
obtained freely from the POPI^-model obtained from the CREATIS labs, Lyon, France 
 ^ [124] was used. Table 5.1 details the obtained patient data.
First section will analyse the breathing pattern and lung tumour motion of the patient 
how much variation occurs during the respiratory cycle. Once the tumour motion 
path is determined, the following section, will then focus on internal and external 
surrogate’s motion paths to build the motion correlation model. First, an analysis of 
the most commonly used non-invasive method for correlation, which is the motion of the 
external surface markers as a surrogate will be evaluated. Thereafter, the motion of the 
internal surrogate organs (lungs and liver in that order respectively) will be evaluated. 
The aim is to determine the feasibility of the proposed correlation model on the clinical 
data  sets, using only the internal surrogate’s motion to build the respiratory-induced 
motion correlation model to help reduce the PTV  margins.
^point validated pixel based consisted of a patient 4DCT acquisitions 
^http: /  /  www.creatis.insa-lyon.fr/rio/popi-model
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5.1 Analysis o f the Extracted Respiratory M otion
As previously explained in Chapter 3, the extraction of respiratory-induced motion is 
the first step in building the respiratory motion correlated model. This is performed 
by using an iterative registration method. The purpose of this extracted respiratory- 
induced motion is tha t it parameterise the tum our and OAR for further analysis. Spa­
tial localisation of the tumour is important, as a number of breathing cycles generally 
occur during a typical radiotherapy treatm ent session. This can be observed in the 
clinical data tha t was obtained via the CREATIS labs [124]. If not properly accounted 
for, this could lead to erroneous treatm ent planning and delivery. In order to extract 
respiratory-induced motion, ICP algorithm was performed with 12 DGF. Higher the 
number of registration parameters would mean higher probability accounting for the 
smallest organ motion. For example, 6 DGF would only accurately account for motion 
in rigid body models, as opposed to 12 DGF where, the motion of deforming organs 
such as lungs, liver, diaphragm, etc... can accurately be described. In this case, 12 
DGF was used to register since, both the surrogate organs (lungs and liver) deform 
due to patient breathing. Furthermore, the tumour is also located inside the lungs, a 
deformable organ. Thus, increased number of registration parameters could describe 
the tum our motion path better than a typical rigid body registration with a minimum 
6 DGF.
The clinical 4D-CT data tha t is used in this chapter details the subtle differences ob­
served as opposed to simulated data analysis. This potentially gives rise to  a more 
realistic correlation model. Lung tum our generally could have a few organs as sur­
rogates, namely, heart, lungs, liver, stomach, spleen. The choice of surrogate organ 
will depend on the visibility and proximity to the lung tumour. In this case however, 
the lung tumour location is positioned in the right lung when visualised and inspected 
with ITKSNAP software. Therefore, the liver and the lungs were chosen as internal 
surrogates to track and analyse the lung tum our motion.
Figure 5.2 illustrates the mean error displacements obtained while extracting the respiratory- 
induced motion, from the lung tumour and the internal surrogate organs, the lungs and 
the liver.
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Lungs wit) timour - POP I/PI
7  400 (Ap) (mm)
F ig u re  5.1: Illustration of the internal surrogate in this case the lungs along with the 
tumour.
It can be observed that the mean error displacement of ±2 mm occurs during the 
breathing cycle of patient 1 of POPI data. The magnitude of these errors also describe 
the pattern of breathing for patient 1 of POPI data. Since, the overall breathing is 
slower and deeper the mean displacement errors which are proportional to the overall 
breathing, also show smaller displacements. Furthermore, Figure 5.3 illustrates the 
successfully converged rms fitting error of the respiratory-induced motion, tha t was 
extracted with the aid of the iterative registration methods as explained in Chapter 3. 
The fitting error curve, only displays the error while performing ICP registration from 
phase 2 (reference) to 1 (source) over the number of iterations. The computational cost 
depends on the size of the organ being registered and also how great the displacement 
is from the reference to the source volume. In the case shown in Figure 5.3, although 
the volume registered was large the displacement was small. Therefore, the conver­
gence begins to occur around the 3^  ^ iteration and finally converges with an error of 
1.2696mm.
Figure 5.4, also illustrates the absolute error plot that demonstrate the tumour trans­
lations are more prone to occur in the SI direction. Although, in some phases such as
5.1. Analysis o f the Extracted Respiratory Motion 93
M ean D isplacem ent E rro r  of Lesion POPI P i
0.4
0.3
0.2
-0.1
-0.2
-0 .3,
re g is te re d  f ram es
(a) RMS error plot for lung tumour. 
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(b) RMS error plot for lungs.
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(c) RMS error plot for liver.
F ig u re  5.2: Figures (a)-(c) illustrates the mean displacement of the RMS error of the 
lung lesion (tumour), lungs and liver for Patient 1 of the POPI data set.
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Figure 5.3: Illustration of the fitting error and convergence graph of lungs from 
P O P I/P l when registering from phase 2 (source) to phase 1 (reference).
the maximum inhale phase, it is also a possibility to observe the high variations in the 
anterior-posterior directions. The high translations occurring in SI and AP directions 
can easily be described by the breathing mechanics. Thus, the expansion in the lungs 
when breathing allows the tumour motion to be moved in either SI or AP directions 
depending on the phase.
Figure 5.5 illustrates that the lesion rotates from left to right direction. This can be 
clearly visible when observing the patient’s original CT data with the aid of ITKSNAP 
visualisation software. As the lungs compress when breathing in and out the lung 
tum our also, by a small margin relatively rotate towards the left or right due to the 
compression. However, it is im portant to note that the rotations occurring in the AP 
and SI directions does not vary as much as in the LR direction.
Figure 5.6 illustrates the scaling of the tumour occurs in the SI direction than in any 
other direction with Patient 1. Since, the observed tumour is located inside the lungs 
and translational motion occurs in the SI direction, it can be inferred that the tumour 
motion behaves proportionally to the lung’s respiratory-induced motion. Thus, as the
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lesion center motion o f POPI/ P I (translations)
registered frames
Figure 5.4: Illustration of the lesion center translations demonstrating error variations 
along each direction (LR, AP, SI) for patient 1 of POPI data.
POPI P i - Rotations
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registered frame
Figure 5.5: Illustration of the displacement errors of the rotation parameter for patient 
1 of POPI data.
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lungs exhale and compress in volume, the tumour will also compress in volume and in 
the same direction. Therefore, scaling occurs in the SI direction.
POPI PI - Scaling
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F ig u re  5.6: Illustration of the displacement errors of the scaling parameter for patient 
1 of POPI data.
Due to rotations occurring in the lateral direction the shearing also occurs more in the 
lateral direction as illustrated in Figure 5.7.
Thus, these registration parameters describe the respiratory-induced motion along with 
the patient’s breathing pattern. This extracted respiratory-induced motion will then 
be used as an input to build the correlation model.
5.2 Evaluation of the Lung Tumour M otion and Breath­
ing Pattern
First and foremost, the lung tumour motion path needs to be evaluated before de­
termining the correlation, with respect to any other surrogates’ motion paths. Since, 
12 parameters were used to extract the respiratory-induced motion from the patient’s 
4D CT data, the data is spanned across the three cardinal axes is high. Therefore, 
as previously demonstrated in Chapter 4, in order to reduce the dimensionality of the 
aforementioned data principal component analysis (PCA) was used.
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Figure 5.7: Illustration of the displacement errors of the shear parameter for patient 
1 of POPI data.
Figure 5.8 illustrates that all the visible principal components are translation param ­
eters in all three dimensions (LR, AP, SI). This means that data representing tumour 
motion has spread across the cardinal axes according to the illustrated variances. An­
other im portant observation is, although 12 DGF was initially used for registering 
the tumour volumes, only 9 parameters are visible. This is due to the fact tha t PC 
algorithm has made the smaller valued parameters redundant. Therefore, shearing 
parameter in any dimension does not appear at all.
Since, the signal of each parameter tha t was used in the registration is illustrated 
Figure 5.9, a clearer number of parameters tha t was used to extract the motion from 
patient 1 of POPI data can be observed. Although, 12 DOF was used earlier to obtain 
the PCs since some of the redundant data was not illustrated observing the signal would 
determine the exact number of parameters was used to register.
In conclusion, the lung tumour in patient 1 tends to move in the lateral direction mostly, 
a reasonable amount of shift in the AP direction and a relatively smaller shift towards 
the SI direction. The smaller shift in the SI direction is due to the heavy scaling tha t is 
occurring in the SI direction. Thus, the patient’s breathing pattern can also be inferred 
since the lung tumour behaves proportional to the patient’s breathing pattern.
98 Chapter 5. Implementation o f the Respiratory-induced Motion Correlation Model
PCA on lesion motion -POPI /PI
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Figure 5.8: Illustration of PCA performed on the lesion of POPI P I data. Although, 
12 DGF were used due to the smaller values it does not appear on the plot as PCA has 
made redundant of such registration parameters.
Signal variation in lesion POPi/PI
!
I
I
Figure 5.9: Illustration of the signal variation that occurs when PCA was performed 
on the extracted lesion (tumour) motion of POPI P I data.
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5.3 M otion Correlation M odel between the External Sur­
face Markers and the Lung Tumour
External surface markers are the most commonly used method when tracking the tu ­
mour motion in the thoracic-abdomen regions [8, 15, 23]. Although, such methods are 
currently in use clinically, placing external markers on the patient would mean th a t 
the observations will also depend with the patient’s anatomy and breathing pattern. 
Therefore, the correlation between the external markers and lung tum our motion is 
analysed for comparison with the internal surrogate organ and lung tum our motion 
correlation.
One salient feature of using the external markers is that, the correlation between the 
external markers and the lung tumours depend entirely on the patient. This could be 
both an advantage as it could give more patient specific models as well as non-invasive 
methods to  correlate motion, as well as a disadvantage, as it depends on the patient’s 
individual structure (muscle thickness, fat under the skin, breathing pattern, e tc ... ) 
and could potentially give rise to determining erroneous tumour locations for treatm ent 
planning and delivery stages.
As a preliminary step however, top most external marker positions were used to cor­
relate the lung tumour motion during respiration. This is to observe and quantify the 
variation tha t occurs when comparing with the external marker positions. The top 
most external surface marker in particular was chosen as this is the most visible and 
most variation observed among all other markers.
As illustrated in Figure 5.11, the observed motion path of the top most anterior marker 
does not always begin and end at the same point in the breathing cycle. This is due to 
the fact tha t breathing is asymmetric and hysteresis occurs as mentioned previously in 
Chapter 2.
Figure 5.12 illustrates the correlation coefficient between the external surface marker 
motion with respect to the lung tumour motion in eigenspace. The correlation coeffi­
cients depict the breathing motion starting with maximum exhale. All the coefficients 
are relatively high as the surface marker is placed closer to the tum our location. As
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Figure 5.10: Illustration of external surface markers on patient 1 of POPI data.
Top Most Anterior Marker Motion During a Breathing Cycle
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Figure 5.11; Illustration of the motion path of the top most anterior marker obtained 
from clinical 4D CT data set.
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the observed surrogate in this case the marker is placed externally to the tum our it has 
a relatively constant correlation coefficient.
CCA between external marker and lung tumour
PCs, Its,,)
I
p(S, Its.,)
frame
F ig u re  5.12: Illustration of the correlation of the lung tumour motion with respect to 
the external surface marker motion in eigenspace. S  is the thoracic/abdominal surface 
marker with respect to lesion motion in LR, AP and SI directions.
5.4 M otion Correlation M odel between Lung Tumour and 
Internal Surrogate
An internal surrogate is an organ tha t is located closest to the target observation and 
that can typically be used as a observation medium internally. This procedure still 
in some cases maybe invasive towards the patient. However, internal surrogate will 
give a better estimate on the observations than if the surrogate was external where 
many factors need to be taken into account when performing observations. Internal
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surrogates can be expected to move in the same way as the lung tumours. Therefore, 
when analysing tumour and OAR’s motion paths during breathing would give a better 
understanding of their movements.
As mentioned earlier since, the lung tumours are growing in the right lung, the liver 
and the lung itself are considered to be pertinent internal surrogates. The diaphragm 
although much closer to the lung tumour, due to its small width and invisibility, it is 
impossible to correctly identify the diaphragm in 4D-CT image data sets. Therefore, 
the diaphragm was not chosen as one of the internal surrogates. First, the motion paths 
of lung and lung tumour will be evaluated. Then the motion paths of liver and lung 
tum our will be evaluated. Finally, the correlation models between the lungs and lung 
tumour, and liver and lung tumour will analysed.
5 .4 .1  E v a lu a tio n  o f  M o tio n  b e tw e e n  th e  L ungs an d  L ung T u m ou r
It is empirical in this research to understand how the lung tumour motion is related 
to  the actual breathing pattern. This is due to  the fact tha t every patient’s breathing 
pattern  not only differs from patient to patient but also during different treatm ent ses­
sions^ [20]. This is of utmost importance in a clinical sense as this will help understand 
the baseline shift of the lung tumour during different treatm ent stages and fractions 
for each individual patient.
The bottom of the lung was chosen as a different viewpoint in observing the lung tumour 
motion. This was performed as a way of determining the best target to correlate the 
lung tum our motion, the surrogate organ (the SI viewpoint from the bottom of the 
lung) or the external markers (in the anterior viewpoint). Although, the viewpoint of 
the lung tum our motion from the bottom of the lungs could mislead at times given 
th a t the tum our itself lies inside the surrogate organ. Therefore, lung tumour motion 
and lung motion is coherent at times. Figure 5.13 illustrates the motion and viewpoint 
of the lungs to  be correlated with the lung tumour.
Since, lungs are considered deformable when registering as aforementioned 12 DOF 
were used. Therefore, in order to  reduce dimensionality PCA was performed and is
®also known as fractions.
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F ig u re  5.13: Illustration of the lung tumour and the bottom of the right lung marked 
in blue. The tumour is illustrated in green.
illustrated in Figure 5.14. Although, 12 DOF were used as input parameters, only 9 
DOF can be visible. This is due to the fact tha t the shear parameter in each of the 
cardinal axes were so small tha t the PCA made shear parameter redundant in all three 
axes.
Figure 5.15 illustrates the signal variation of the lungs. The signal variation as stated 
previously allows to observe accurately the true number of parameters that was used 
to describe the extracted motion. This clearly illustrates that the lungs rotate around 
the LR axis (the rotational parameter t/j). As the breathing occurs the lungs expand, it 
expands in the AP direction and rotate around the LR axis. This verifies the patien t’s 
breathing pattern.
The individual quiver plots describe the velocity and directionality of the center of the 
lung tum our’s motion path with respect to the bottom of the lungs along the three 
cardinal axes. These are almost proportional to the motion pa th ’s obtained previously 
in the signal variations.
If the location is closer to the bottom of the lungs then another internal surrogate would
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F ig u re  5.14: Illustration of the principal components obtained from the lungs of patient 
1 of PO PI data.
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F ig u re  5.15: Illustration of the signal variation of the extracted motion for lungs during 
the breathing cycle.
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F ig u re  5.16: Illustration of the directionality in the x direction of the lesion center’s 
motion with respect to the bottom of the lung. The start position is denoted with a 
red +  sign.
be the diaphragm. However, the nature of the diaphragm is almost invisible in the 4D 
CT image data sets and segmenting the diaphragm lead to more errors being presented. 
Therefore, an alternative surrogate tha t is located closest to the lung tum our the liver 
was chosen.
5 .4 .2  E v a lu a tio n  o f  M o tio n  b e tw e e n  th e  L iver and  L u n g  T u m ou r
Liver is one of the largest and easily visible organs in the abdominal region. Therefore, 
liver can be accurately located in 4D CT image data sets without any obvious ambi­
guities. Since, all of the clinical data are only 4D-CT, the high visibility and the close 
proximity in anatomy makes the liver an ideal internal surrogate for the tum our in this 
case. Although, affected by the respiratory motion, the liver is still considered to be a 
plausible internal surrogate. Figure 5.19 illustrates the principal components obtained 
for the liver of patient 1 shown in Table 5.1.
As mentioned previously, the smallest values are made redundant by the PCA. There­
fore, as in the case of the lung tumour motion the smallest values are generated by
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Directionality of lesion motion as compared to bottom of lung -  y dimension
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F ig u re  5.17: Illustration of the directionality in the y direction of the lesion center’s 
motion with respect to the bottom of the lung. The start position is denoted with a 
red +  sign.
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F ig u re  5.18: Illustration of the directionality in the z direction of the tumour center 
with respect to the bottom of the lung. The start position is denoted with a red +  
sign.
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Figure 5.19: Illustration of the PCA performed on the liver of PO PI P I data.
the shear parameters. Thus, these are not illustrated in the PC plot. However, it can 
be clearly seen that most motion occurs along the translational parameters along the 
left-right (LR) direction with ~90% variation. The volume compression of the lungs 
due to exhalation pushes down the diaphragm, thus, any OAR further down. However, 
due to the anatomical structure this cannot be fully attained as other organs take space 
and therefore, motion in the liver occurs in the lateral direction. In order to verify the 
number of parameters used in the PCA to obtain the principal dimension of motion 
in the liver, the signal variation illustrated in Figure 5.20 can be observed. The signal 
variation also describes the liver motion occurring as rotations along the LR direction 
with relative translations occurring in the SI direction. This explains the breathing 
pattern of the patient as, the lungs exhale the compression on the diaphragm and the 
subsequent organs beneath causes the liver motion to be in the form of rotations along 
the LR axis and smaller translational variations in the SI direction.
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F ig u re  5.20: Illustration of the signal variation on liver when PCA was performed of 
PO PI P I data.
5 .4 .3  E v a lu a tio n  o f  R esp ira to ry -in d u ced  C o rre la tio n  M o d e l B e tw een  
In tern a l S u rro g a te  an d  L ung T um our M o tio n
As previously mentioned in chapter 4, this method is used to build a correlation model 
between the internal surrogate organs and the lung tumour motion. This method is 
im portant considering the amount of information it relays which is important when 
building patient specific models accounting for the respiratory-induced motion.
Figure 5.21 illustrates the correlation between the motion in the lung tumour with 
respect to the internal surrogate lungs in eigenspace. Each of the registered parameters 
are correlated and varies between ±2.5. It can be seen tha t although 12 DOF were used 
to perform registrations due to the minute variations in certain parameters they have 
been automatically made redundant. Hence, the matched parameters are less than the 
actual parameters used as input to generate the correlations. It is also visible that 
across all the respiratory phases a significant correlation coefficient exists. This again 
can be concluded due to the close proximity of the tumour and observation source.
Figure 5.22 illustrates the correlation between the motion between the lung tumour
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F ig u re  5.21: Correlation model of the lung tumour and internal surrogate lungs in 
eigenspace.
with respect to the internal surrogate the liver in eigenspace. Many of the correlation 
coefficients of the rotational and some scaling parameters are higher than the rest of the 
parameters. This is expected due to the breathing mechanics of the liver. It can also 
be seen that a maximum parameter variation occurs at maximum inhalation phases 
between frames 4 to 6. In this case, as in the correlation between lung tum our motion 
with respect to the lungs motion, the number of parameters actually used cannot all 
be visible. This is due to the fact tha t some input registration parameters are made 
redundant due to its small variations occurring during the observed breathing cycles.
5.5 Feasibility with Different Patients
This chapter reviews the feasibility of the proposed correlation model. This has been 
implemented on clinical data obtained by the CREATIS Labs in Lyon, France as well 
as the clinical data obtained by the RSCH^. Although, this model may give better 
correlations with the tumour model it is still in the early stages of development of using
ffioyal Surrey County Hospital
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F ig u re  5.22: Correlation model of the lung tumour and internal surrogate liver in 
eigenspace.
in clinical terms. This is mainly due to the fact tha t image acquisition and treatment 
is still heavily based on external markers. However, when the above correlation model 
was used on all the patients shown in Table 5.1, it can be seen a correlation coefficient 
varying most at the maximum inhalation.
5.6 Summary
This chapter aims to implement the respiratory-induced motion correlation model that 
was discussed in the previous chapter. The respiratory-induced tumour motion was first 
correlated between the external surface markers, which is the conventional method of 
correlating respiratory-induced motion. It then correlates the respiratory-induced tu ­
mour motion between the internal surrogates. In this case, the lung and the liver 
were chosen as pertinent internal surrogates. It can be observed tha t although internal 
surrogates are difficult to monitor than the external surface markers for tumour cor­
relation, the accuracy of using internal surrogates offer a higher margin of correlation 
as opposed to using external surface markers. This is due to the fact that, external
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surface markers rely heavily on patient anatomies and set up errors occurring during 
treatm ent sessions. However, when using internal surrogates, all surrogate organs can 
be easily correlated without being affected of the individual patient anatomy or set 
up errors. This is im portant when building a correlation model th a t can be adaptable 
to all patients. By observing the tumour motion so accurately would mean th a t the 
tumour motion path can be easily determined. Hence, knowing the motion path of the 
tumour would mean the reduction of the PTV margin can be carried out.
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Chapter 6
Conclusions and Future Work
External beam radiotherapy (EBRT) is a popular non-invasive method of treating can­
cer patients. Since, the most prevalent type of cancer is lung cancer, this research 
focuses specially on radiation treatm ent of lung tumours. Although, many advanced 
EBRT treatm ent methods are in use these days, one critical factor tha t affects all 
state-of-the-art imaging systems is the ambiguities (such as blurriness, e tc ...) th a t oc­
cur while the patient breathes during treatm ent sessions. Thus, these ambiguities of 
the lung tumour location in the scanned images could lead to potentially erroneously 
determining the dosage during the radiation treatm ent planning and delivery stages.
A key element tha t considers in this research is the reduction of the errors of the 
planning target volume (PTV) margin. In order to achieve this goal the tum our’s 
motion path needs to be known in a definitive manner. To obtain this motion path  a 
correlation model tha t is solely focused on monitoring the tumour motion internally is 
presented.
6.1 Concluding Discussion
A framework tha t takes into account respiratory-induced motion th a t relates internal 
organ motion with the tumour motion without the need of external markers have been 
presented. This research has focused on describing the tumour motion with respiration
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by means of looking into various aspects of managing and modeling the respiratory- 
induced motion. A few different internal and external models have been analysed. The 
first model was to describe the lung tumour motion by way of correlating to the external 
marker positions. This model depends heavily on certain criteria such as patient size, 
breathing, human error^ to  perform optimally. The second model described the internal 
surrogate organ’s motion with respect to the lung tum our being observed. Since, the 
tum our in the thoracic-abdomen region tha t is been examined is a lung tumour, the 
lung was chosen as the closest surrogate. Another surrogate o rg a n ’s motion was also 
examined so as to validate and observe the improvement should there be any.
The first part of this research is to quantify and extract the respiratory-induced motion. 
This was carried out with the aid of simulated data that was obtained by XCAT 
phantom and as well as with clinical data. The quantification of tumour motion is a 
key aspect in this research as this will later help determine the target volume margins 
for treatm ent purposes. It can be shown tha t the errors occurring in XCAT were much 
less than in clinical data since XCAT assumes idealistic parameters.
The next major component of the thesis is to  build a correlation model tha t efficiently 
describe the respiratory-induced motion paths between the tumour and the internal or 
external surrogate. This was achieved with the aid of PC A to reduce dimensionality 
from the extract respiratory-induced motion. Subsequently, using CCA to build the 
correlation model between the lung tumour and the surrogate. The external surface 
marker positions were chosen to describe the motion in the thoracic/abdominal surface 
during breathing. This was then correlated with the internal lung tumour motion path, 
building a correlation model to track the thoracic/abdominal surface-internal tumour 
motion paths. Next, the motion between the internal surrogate and the lung tumour 
was correlated. The internal surrogates were chosen depending on the proximity to the 
target tum our location and the visibility on the 4D CT image data sets. Therefore, 
for the purpose of this research the lungs and liver were chosen as internal surrogates. 
Although, both internal surrogates provided with much better results than the external 
surface markers, it can be concluded tha t depending on the location of the tumour inside
 ^since radiotherapy treatment does not occur on the same day radiologists can and may place 
external markers closest to a certain point on the anterior surface but never on the same place.
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the lung, the liver could potentially give better results if the tumour was located closer 
to the bottom of the lung.
The final component of the thesis is the feasibility match of the aforementioned cor­
relation model to the actual clinical data sets. This was carried out across 5 sets 4D 
CT image data sets of patients. The comparative study provided with the maximum 
variation occurring phases and their respective directionality at which the variation was 
occurring. This quantification of correlation between the tumour and internal surrogate 
motion, provided with the amount of variation tha t could minimise the PTV  margin 
for radiation treatment.
6.2 Future Work
The following are some of the key areas in EBRT for lung tum our treatm ent tha t are 
open for improvement.
• Typically, radiotherapy treatm ent stages do not occur on the same day. This 
usually occurs over a period of time in small doses, a procedure well-known as 
fractionisation. Even though, the respiratory-induced motion is accounted for, 
treatm ent planning stage occurs much earlier than the treatm ent delivery. Thus, 
the PTV  margins tha t was supposedly in one location may not necessarily be in 
the exact same area during the delivery stages, due to baseline shifting of the 
tumour. It would be beneficial to understand how to account for this shift in 
baseline, thus, reducing further the overall PTV margin.
• Another interesting area in EBRT tha t is open for improvement is to account for 
the involuntary respiratory-induced motion and adjusting the treatm ent margins 
dynamically during treatm ent delivery stage.
• Accounting for microscopic extensions of the tumour from treatm ent planning 
stage to treatm ent delivery stage is also open for improvement.
• If internal organ structures were to be used as surrogates a non-invasive procedure 
to monitor the motion.
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•  Finally, accounting for the system latency in producing beam profiles is another 
key area to improve.
A ppendix A
Glossary
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EBRT External Beam Radiotherapy
G TV Gross Tumour Volume Margin
CTV Clinical Target Volume Margin
P T V Planning Target Volume Margin
LINAC Linear Accelerator
OAR Organs at Risk
3D 3-Dimensional
4D 4-Dimensional
CT Computed Tomography
D D F Degrees of Freedom
4D C T 4-dimensional Computed Tomography
C BC T Cone-beam Computed Tomography
3D -CR T 3-dimensional Conformai Radiotherapy
IGRT Image Guided Radiotherapy
IM RT Image Modulated Radiotherapy
MLC Multi-leaf Collimator
DM LC Dynamic Multi-leaf Collimator
RTRT Real-time tumour-tracking Radiotherapy
A P Anterior-Posterior
LR Left-Right
SI Superior-Inferior
A BC Active Breathing Control
FSB Forced Shallow Breathing
PG A Principal Component Analysis
PC Principal Components
CCA Canonical Correlation Analysis
A ppendix B
Radiotherapy Treatment 
M achines
B .l  Linear Accelerator
A linear accelerator or linac, is a machine tha t is used in conventional radiotherapy 
treatm ent procedures. Figure B .l illustrates the working mechanics of a linac machine. 
Linac machines generate high-energy X-ray beams. RF waves th a t are pulsed into a 
magnetron by the waveguide^. This is synchronised with the injection of electrons into 
the waveguide by the electron gun. RF waves will accelerate the electrons along the 
waveguide. These electron beams collide and interact with a tungsten target on the 
opposite end and emits X-rays. The magnetron controls the magnitude and frequency 
of the RF waves to control the energy of the X-ray beam. The number of electrons 
injected will be controlled by the tungsten filament tha t is used to generate these 
electrons by increasing temperature. The high energy electrons are then focused to  a 
tungsten target where the energy is converted to  photons. These high energy photons 
emerge from the target in a variety of directions. The primary collimator is in the 
shape of a cone beam.
To accelerate electrons in a part of the accelerator called the ’’wave guide,” then allows
^vacuum chamber
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these electrons to  collide with a heavy metal target. As a result of the collisions, high- 
energy x-rays are produced from the target. These high energy x-rays are shaped as 
they exit the machine to conform to the shape of the patient’s tumor and the customized 
beam is directed to the patient’s tumor. The beam may be shaped either by blocks that 
are placed in the head of the machine or by a multileaf collimator tha t is incorporated 
into the head of the machine. The patient lies on a moveable treatment couch and 
lasers are used to make sure the patient is in the proper position. The treatm ent couch 
can move in many directions including up, down, right, left, in and out. The beam 
comes out of a part of the accelerator called a gantry, which can be rotated around 
the patient. Radiation can be delivered to the tumor from any angle by rotating the 
gantry and moving the treatm ent couch.
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t a r g e t e d  a n d  h e a l t h y  
t i s s u e s  a r e  p r o t e c t e d .
F ig u re  B .l: Illustration of the linear accelerator [120]
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B.2 M ulti-Leaf Collimator (MLC)
A multileaf collimator (MLC) is a device where individual leaves of tungsten, can move 
independently from the path of a particle beam in order to block it. MLC these are 
typically seen on linac machines to allow the beams to conform into the shape of the 
tumour.
F ig u re  B.2: MLC collimator adjusting according to the shape of the tum our [1].
Figure B.2 illustrates the plates conforming according to the shape of the tumour. Such 
methods minimise healthy tissues surrounding the tumour to be spared.
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A ppendix C
Tabulated Raw D ata
Frame LR (x) A P  (y) SI (z)
1 429.7512 327.9106 166.7206
2 429.5566 327.8934 166.5742
3 429.2619 327.9609 166.7812
4 429.0711 327.9547 166.9863
5 428.9914 327.9165 167.0620
6 428.9097 327.8922 166.9706
7 428.8929 327.8795 166.8406
8 429.1038 327.9642 166.8326
9 429.3550 327.9544 166.7715
10 429.5629 327.9238 166.7894
T ab le  C .l: Coordinates obtained from the top most external surface marker from 
clinical data.
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